drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Haloperidol	Biperiden	0.513	-1.992	Moderate	560 (200/360)		#AECDE3	58.4864337583696	0
Omeprazole	Diazepam	0.333	1.685	Moderate	32638 (21248/11390)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F7B7B7	3408.71468751012	1
Amiodarone	Acenocoumarol	0.369	-3.624	None	765 (179/586)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#A0C3DD	79.8966461163441	0
Omeprazole	Alprazolam	0.274	1.948	Moderate	20267 (13845/6422)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F6B6B6	2116.68670175156	1
Mesalazine	Azathioprine	0.415	-1.34	Moderate	473 (214/259)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B2D0E5	49.4001485137657	0
Indomethacin	Methotrexate	0.31	1.53	Major	781 (491/290)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F7B9B9	81.567687080869	0
Digoxin	Furosemide	0.395	-2.418	Moderate	570 (179/391)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#A9C9E1	59.5308343611976	0
Pravastatin	Fenofibrate	0.835	-2.983	Major	1234 (334/900)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#A6C7E0	128.879034388979	0
Trimethoprim	Leucovorin	0.517	-3.026	Major	616 (165/451)		#A5C6DF	64.3350771342065	0
Omeprazole	Clonazepam	0.279	1.516	Moderate	5682 (3560/2122)		#F7B9B9	593.428422526885	1
Digoxin	Spironolactone	0.421	-2.438	Minor	253 (79/174)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#A9C9E1	26.4233352515491	3.56601000743206e-278
Methotrexate	Hydroxychloroquine	0.305	3.921	Minor	267 (217/50)		#EFA6A6	27.8854960955083	3.52927589236412e-226
Digoxin	Amiodarone	0.4	-3.625	Major	171 (40/131)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#A0C3DD	17.8592503083593	1.01341281345717e-227
Entacapone	Apomorphine	0.286	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	0.224746581492722
Acetylsalicylic acid	Insulin aspart	0.323	-2.533	Moderate	1710 (520/1190)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#A9C9E1	178.592503083593	0
Warfarin	Amiodarone	0.311	-2.562	Major	116 (35/81)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#A9C9E1	12.1150469928051	5.71016428901536e-149
Omeprazole	Methotrexate	0.312	1.84	Major	2909 (1951/958)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F6B6B6	303.816135362673	6.92523574404302e-105
Carbamazepine	Levetiracetam	0.523	-1.69	Moderate	288 (114/174)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#AFCEE4	30.0787373614472	1.00043519999216e-264
Digoxin	Carvedilol	0.365	-5.114	Moderate	281 (50/231)	Digoxin may increase the bradycardic activities of Carvedilol.	#96BBD9	29.3476569394676	1.45274162315553e-315
Trihexyphenidyl	Haloperidol	0.472	-1.107	Moderate	38 (19/19)		#B4D1E6	3.96872229074651	6.51498552112279e-51
Acetylsalicylic acid	Gliclazide	0.371	-3.552	None	2037 (484/1553)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#A2C4DE	212.744402796069	0
Acetylsalicylic acid	Glyburide	0.353	-2.704	Moderate	1119 (325/794)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#A8C8E1	116.868427456456	4.03412733480184e-247
Amitriptyline	Duloxetine	0.326	6.29	Major	860 (752/108)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#E69393	89.8184518432104	7.33658772353817e-93
Alendronic acid	Ibuprofen	0.172	12.759	Moderate	2571 (2401/170)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#D06060	268.515394987086	1
Acetylsalicylic acid	Ibuprofen	0.16	-1.766	Major	8104 (3122/4982)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#AFCEE4	846.382248531834	1
Propranolol	Rizatriptan	0.29	3.935	Moderate	316 (257/59)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#EFA6A6	33.0030590493657	1.35942829773984e-109
Acetaminophen	Acenocoumarol	0.212	-1.68	None	2528 (1004/1524)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	264.024472394925	1
Atenolol	Ibuprofen	0.164	1.064	Moderate	3783 (2046/1737)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F9BCBC	395.096748049843	1
Fenofibrate	Atorvastatin	0.468	-4.631	Major	1695 (327/1368)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#99BDDA	177.025902179351	1.27467965507881e-261
Tramadol	Citalopram	0.218	3.125	Major	2096 (1626/470)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F2ACAC	218.906366352755	1
Tramadol	Fluoxetine	0.216	5.933	Major	1627 (1412/215)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#E89696	169.92397808012	1
Lamotrigine	Carbamazepine	0.49	-1.163	Moderate	162 (79/83)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B4D1E6	16.9192897658141	4.29826138984943e-114
Acetylsalicylic acid	Insulin detemir	0.301	-2.332	Moderate	522 (168/354)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#ABCBE2	54.5177114676231	4.3884104966155e-154
Bisoprolol	Ibuprofen	0.143	-1.303	Moderate	4183 (1921/2262)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B2D0E5	436.872772162964	1
Valproic acid	Carbamazepine	0.544	-1.931	Moderate	247 (90/157)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#AECDE3	25.7966948898523	8.19236587695722e-161
Levothyroxine	Iron	0.2	31.882	Moderate	871 (847/24)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#B32020	90.9672925063212	1.93537508492468e-07
Digoxin	Verapamil	0.408	-1.208	Moderate	46 (22/24)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#B2D0E5	4.80424277300893	6.07660875154786e-37
Fluvoxamine	Clomipramine	0.46	-1.089	Major	123 (62/61)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#B4D1E6	12.8461274147847	3.05813603383689e-97
Omeprazole	Ketazolam	0.266	2.273	None	1206 (863/343)		#F5B2B2	125.95471270106	1
Amitriptyline	Fluoxetine	0.314	7.633	Major	841 (752/89)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#E18888	87.8340906978372	1
Repaglinide	Gliclazide	0.249	-1.667	None	223 (89/134)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	23.290133443065	6.30075789531858e-67
Diltiazem	Atorvastatin	0.474	-3.03	Moderate	568 (152/416)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#A5C6DF	59.321954240632	5.19234715598139e-166
Mesalazine	Mercaptopurine	0.35	-1.181	Moderate	31 (15/16)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	3.23764186876689	8.11505340510795e-38
Haloperidol	Lithium cation	0.363	-1.493	Major	101 (43/58)	Lithium may increase the neurotoxic activities of Haloperidol.	#B1CFE5	10.5484460885631	1.71713890082959e-76
Tacrolimus	Atorvastatin	0.419	-1.717	Moderate	597 (234/363)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#AFCEE4	62.3507159888333	5.02970450874831e-67
Tramadol	Paroxetine	0.195	3.655	Major	1650 (1323/327)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F0A7A7	172.326099466625	1
Cholestyramine	Ursodeoxycholic acid	0.319	2.452	None	52 (38/14)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F4B1B1	5.43088313470575	9.85866257662816e-37
Simvastatin	Fenofibrate	0.4	-3.274	Major	1856 (469/1387)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#A3C5DF	193.840751884882	0.000222627384091023
Sulfasalazine	Azathioprine	0.518	1.737	Moderate	38 (25/13)		#F7B7B7	3.96872229074651	1.74970340932568e-31
Propranolol	Ibuprofen	0.198	2.179	Moderate	1713 (1211/502)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F5B4B4	178.905823264441	1
Methotrexate	Naproxen	0.247	1.886	Major	809 (547/262)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F6B6B6	84.4920087687875	1
Ranolazine	Diltiazem	0.349	-1.107	Major	20 (10/10)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#B4D1E6	2.08880120565606	3.9220229483557e-17
Propafenone	Acenocoumarol	0.324	-2.056	None	60 (21/39)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#ACCCE3	6.26640361696817	1.92260721034598e-48
Phenytoin	Lamotrigine	0.507	-1.832	Moderate	77 (29/48)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#AECDE3	8.04188464177582	1.10745752365391e-60
Tramadol	Escitalopram	0.217	2.904	Major	1041 (794/247)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F2AEAE	108.722102754398	1
Carbamazepine	Risperidone	0.399	-1.966	Moderate	161 (58/103)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#AECDE3	16.8148497055313	2.55510245432158e-82
Fluoxetine	Clomipramine	0.348	2.042	Major	326 (226/100)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F5B4B4	34.0474596521937	4.78150976749466e-27
Torasemide	Ibuprofen	0.191	2.091	Moderate	1180 (824/356)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F5B4B4	123.239271133707	1
Cyclosporine	Allopurinol	0.364	-3.485	Moderate	112 (27/85)		#A2C4DE	11.6972867516739	1.82234181332453e-41
Prednisone	Acetylsalicylic acid	0.221	-1.644	Moderate	1722 (693/1029)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#AFCEE4	179.845783806986	1
Topiramate	Lithium cation	0.332	1.293	Moderate	141 (83/58)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F8BABA	14.7260484998752	9.18677149388135e-50
Simvastatin	Clarithromycin	0.11	1.226	Major	1572 (905/667)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F8BABA	164.179774764566	1
Acetylsalicylic acid	Insulin glulisine	0.287	-2.818	Moderate	273 (77/196)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#A6C7E0	28.5121364572052	1.08338418372295e-80
Furosemide	Ibuprofen	0.239	1.242	Moderate	1743 (1009/734)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F8BABA	182.039025072925	1
Carbamazepine	Simvastatin	0.364	1.024	Moderate	478 (254/224)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	49.9223488151797	1
Propranolol	Paroxetine	0.299	2.551	Moderate	455 (336/119)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F4B1B1	47.5202274286753	1
Fluvoxamine	Olanzapine	0.487	-1.882	Moderate	108 (40/68)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#AECDE3	11.2795265105427	1.46582539761403e-64
Tacrolimus	Nifedipine	0.464	-2.44	Moderate	141 (44/97)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#A9C9E1	14.7260484998752	3.70833367408624e-81
Diltiazem	Amiodarone	0.341	-3.03	Major	71 (19/52)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#A5C6DF	7.415244280079	1.90111495877357e-45
Omeprazole	Itraconazole	0.194	1.519	Moderate	1346 (844/502)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F7B9B9	140.576321140653	1
Alprazolam	Clarithromycin	0.154	2.581	Moderate	1103 (817/286)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F4B1B1	115.197386491931	1
Acetylsalicylic acid	Acenocoumarol	0.302	-3.528	None	670 (160/510)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#A2C4DE	69.9748403894779	2.38587845372823e-22
Omeprazole	Midazolam	0.256	1.415	Moderate	480 (293/187)		#F7B9B9	50.1312289357453	1
Diclofenac	Alendronic acid	0.174	7.699	Moderate	838 (750/88)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#E18888	87.5207705169887	1
Spironolactone	Enalapril	0.412	-3.158	Major	836 (217/619)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#A5C6DF	87.3118903964231	5.83014642011876e-15
Fenofibrate	Rosuvastatin	0.445	-4.981	Major	396 (72/324)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#97BCD9	41.3582638719899	2.81117561804548e-114
Levothyroxine	Acenocoumarol	0.293	1.87	None	353 (238/115)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F6B6B6	36.8673412798294	1
Cyclosporine	Carvedilol	0.5	-1.923	Moderate	52 (19/33)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#AECDE3	5.43088313470575	1.06186428208594e-27
Simvastatin	Gemfibrozil	0.266	-3.624	Major	1483 (347/1136)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#A0C3DD	154.884609399397	1
Trimethoprim	Rifampicin	0.538	-1.575	Moderate	63 (26/37)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#B1CFE5	6.57972379781658	7.93626625975888e-33
Omeprazole	Flurazepam	0.259	1.643	Moderate	420 (271/149)		#F7B7B7	43.8648253187772	1
Topiramate	Carbamazepine	0.5	-1.277	Moderate	168 (78/90)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B2D0E5	17.5459301275109	9.52801968056659e-57
Cyclosporine	Sulfamethoxazole	0.277	-2.743	Major	80 (23/57)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	8.35520482262422	2.58434141636209e-60
Amitriptyline	Salbutamol	0.191	4.15	Moderate	744 (611/133)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#EEA4A4	77.7034048504053	1
Propranolol	Escitalopram	0.285	1.735	None	333 (219/114)		#F7B7B7	34.7785400741733	0.00212366850602143
Repaglinide	Glyburide	0.243	-2.004	None	104 (37/67)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#ACCCE3	10.8617662694115	2.83625882080658e-30
Sucralfate	Lansoprazole	0.39	1.52	Moderate	110 (69/41)		#F7B9B9	11.4884066311083	5.21673276759191e-27
Alendronic acid	Naproxen	0.175	10.405	Moderate	726 (668/58)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#D87373	75.8234837653148	1
Galantamine	Risperidone	0.366	1.129	Moderate	9 (5/4)		#F9BCBC	0.939960542545225	8.36190934610334e-09
Fluoxetine	Propranolol	0.3	2.88	Moderate	335 (255/80)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F2AEAE	34.9874201947389	1
Diltiazem	Simvastatin	0.428	-2.295	Major	504 (164/340)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#ABCBE2	52.6377903825326	3.28062232345669e-11
Propranolol	Primidone	0.288	-1.199	Moderate	25 (12/13)	The metabolism of Propranolol can be increased when combined with Primidone.	#B4D1E6	2.61100150707007	4.13821626639893e-21
Bisoprolol	Gliclazide	0.341	-3.513	None	601 (144/457)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#A2C4DE	62.7684762299645	1.12950832673863e-14
Warfarin	Propafenone	0.371	-1.845	Moderate	16 (6/10)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#AECDE3	1.67104096452484	2.15747106119951e-15
Haloperidol	Carbamazepine	0.4	-1.542	Moderate	67 (28/39)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#B1CFE5	6.99748403894779	3.51379453087863e-33
Methotrexate	Amoxicillin	0.116	1.89	Major	773 (523/250)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F6B6B6	80.7321665986066	1
Citalopram	Propranolol	0.29	2.083	Moderate	400 (279/121)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F5B4B4	41.7760241131211	1
Rizatriptan	Escitalopram	0.209	8.482	Major	187 (169/18)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#DF8181	19.5302912728841	0.471177944911124
Venlafaxine	Metoclopramide	0.126	3.153	Moderate	458 (356/102)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F2ACAC	47.8335476095237	1
Fluconazole	Alprazolam	0.175	2.546	Major	588 (434/154)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F4B1B1	61.410755446288	1
Phenytoin	Omeprazole	0.319	-1.655	Moderate	484 (194/290)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#AFCEE4	50.5489891768766	1
Atenolol	Gliclazide	0.311	-2.163	None	387 (131/256)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	40.4183033294447	0.0685696381127744
Methotrexate	Ibuprofen	0.182	2.021	Major	777 (537/240)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F5B4B4	81.1499268397378	1
Fluconazole	Simvastatin	0.107	1.235	Major	741 (428/313)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F8BABA	77.3900846695569	1
Propranolol	Sertraline	0.306	2.063	Moderate	266 (185/81)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F5B4B4	27.7810560352255	1
Clozapine	Haloperidol	0.252	-2.878	Major	18 (5/13)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#A6C7E0	1.87992108509045	1.30052261599195e-20
Ibuprofen	Lithium cation	0.142	1.543	Moderate	547 (345/202)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F7B9B9	57.1287129746931	1
Bisoprolol	Salbutamol	0.161	-1.408	Moderate	877 (386/491)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	91.5939328680181	1
Sumatriptan	Ergotamine	0.327	3.097	Major	62 (48/14)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F2ACAC	6.47528373753377	2.21338179566025e-20
Cyclosporine	Omeprazole	0.369	-1.558	Moderate	390 (162/228)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B1CFE5	40.7316235102931	1
Levothyroxine	Raloxifene	0.319	63.538	Moderate	214 (211/3)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	22.3501729005198	1
Fluoxetine	Risperidone	0.386	-1.081	Moderate	253 (128/125)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#B4D1E6	26.4233352515491	6.19738230602304e-08
Carbamazepine	Atorvastatin	0.342	-1.45	Moderate	231 (100/131)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B1CFE5	24.1256539253274	0.204274819873052
Atorvastatin	Gemfibrozil	0.3	-4.559	Major	778 (152/626)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#9ABEDB	81.2543669000206	1
Raloxifene	Estriol	0.323	Inf	None	44 (44/0)		#B32020	4.59536265244332	7.46230745837303e-18
Acetaminophen	Warfarin	0.222	-1.552	Minor	394 (164/230)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B1CFE5	41.1493837514243	1
Allopurinol	Acenocoumarol	0.324	-9.567	None	405 (42/363)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#74A1CA	42.2982244145351	1.6134578572641e-60
Citalopram	Clarithromycin	0.14	3.413	Major	559 (442/117)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F0A9A9	58.3819936980868	1
Zolmitriptan	Ergotamine	0.316	3.822	Major	68 (55/13)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#EFA6A6	7.10192409923059	2.41375556786872e-17
Spironolactone	Losartan	0.409	-1.448	Major	180 (78/102)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#B1CFE5	18.7992108509045	0.350025106129192
Omeprazole	Halazepam	0.248	2.357	Moderate	249 (180/69)		#F5B2B2	26.0055750104179	1
Atenolol	Salbutamol	0.15	-1.049	Moderate	664 (341/323)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	69.3482000277811	1
Paroxetine	Risperidone	0.372	1.008	Moderate	256 (135/121)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F9BCBC	26.7366554323975	1
Bisoprolol	Insulin aspart	0.274	-2.935	Moderate	314 (86/228)		#A6C7E0	32.7941789288001	3.49638262586577e-09
Pyridostigmine	Prednisone	0.433	1.287	Moderate	80 (47/33)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#F8BABA	8.35520482262422	1.38879533363518e-20
Fluoxetine	Clarithromycin	0.137	6.613	Moderate	416 (366/50)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#E59090	43.447065077646	1
Amitriptyline	Carbamazepine	0.359	2.151	Moderate	142 (100/42)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F5B4B4	14.830488560158	0.0158886638628726
Paroxetine	Rizatriptan	0.243	8.402	Major	206 (186/20)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#DF8383	21.5146524182574	1
Citalopram	Acenocoumarol	0.29	-1.14	None	274 (135/139)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#B4D1E6	28.616576517488	1
Valproic acid	Acetylsalicylic acid	0.368	-2.29	Moderate	356 (116/240)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#ABCBE2	37.1806614606778	1
Citalopram	Zolmitriptan	0.227	10.615	Major	204 (188/16)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#D77272	21.3057722976918	1
Citalopram	Rizatriptan	0.224	4.889	Major	218 (184/34)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#EB9E9E	22.767933141651	1
Zolmitriptan	Paroxetine	0.2	7.391	Major	202 (180/22)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#E38B8B	21.0968921771262	1
Acetylsalicylic acid	Glipizide	0.378	-1.925	Moderate	63 (23/40)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#AECDE3	6.57972379781658	4.66576070730135e-15
Donepezil	Quetiapine	0.428	1.004	Moderate	19 (10/9)		#F9BCBC	1.98436114537325	1.67985582849447e-12
Fluoxetine	Rizatriptan	0.235	9.335	Major	170 (155/15)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#DC7B7B	17.7548102480765	1
Fluoxetine	Dextromethorphan	0.123	6.499	Major	295 (259/36)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#E69191	30.8098177834268	1
Colestipol	Ursodeoxycholic acid	0.17	1.581	None	11 (7/4)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F7B9B9	1.14884066311083	9.69138971983222e-07
Methotrexate	Flurbiprofen	0.241	1.129	Major	18 (10/8)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#F9BCBC	1.87992108509045	4.42732503387448e-12
Methadone	Cimetidine	1	Inf	Moderate	1 (1/0)	The metabolism of Methadone can be decreased when combined with Cimetidine.	#B32020	0.104440060282803	1
Carvedilol	Insulin aspart	0.321	-4.391	Moderate	149 (30/119)		#9CBFDB	15.5615689821376	2.04432090340558e-39
Carbamazepine	Aripiprazole	0.312	1.236	Moderate	45 (26/19)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#F8BABA	4.69980271272613	1.60054772115277e-11
Diazepam	Clarithromycin	0.284	2.55	Moderate	883 (652/231)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F4B1B1	92.2205732297149	1
Ibuprofen	Carvedilol	0.122	-2.03	Moderate	802 (283/519)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#ACCCE3	83.7609283468078	1
Sertraline	Clarithromycin	0.128	3.216	Moderate	342 (267/75)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F1ABAB	35.7185006167186	1
Phenytoin	Oxcarbazepine	0.419	-1.811	Moderate	29 (11/18)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#AECDE3	3.02876174820128	1.45476875017223e-14
Erythromycin	Alprazolam	0.133	3.46	Moderate	256 (203/53)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F0A9A9	26.7366554323975	1
Disopyramide	Bisoprolol	0.246	-2.583	Major	10 (3/7)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#A9C9E1	1.04440060282803	5.35214523030774e-08
Prednisone	Acenocoumarol	0.197	-1.454	None	317 (137/180)		#B1CFE5	33.1074991096485	1
Zolmitriptan	Escitalopram	0.213	4.445	Major	148 (123/25)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#EDA1A1	15.4571289218548	1
Zolmitriptan	Fluoxetine	0.232	8.913	Major	163 (148/15)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#DD7E7E	17.0237298260969	1
Atenolol	Glyburide	0.319	-2.474	Moderate	220 (68/152)	Atenolol may increase the hypoglycemic activities of Glyburide.	#A9C9E1	22.9768132622166	9.17798178767429e-06
Bisoprolol	Formoterol	0.208	-1.585	Moderate	467 (192/275)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B1CFE5	48.7735081520689	1
Gentamicin	Ceftriaxone	0.5	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Cimetidine	Doxepin	0.375	Inf	Moderate	1 (1/0)	The metabolism of Doxepin can be decreased when combined with Cimetidine.	#B32020	0.104440060282803	1
Ibuprofen	Acenocoumarol	0.153	-1.631	None	804 (325/479)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	83.9698084673735	1
Cyclosporine	Ursodeoxycholic acid	0.423	-3.321	Minor	48 (12/36)		#A3C5DF	5.01312289357453	1.54752978849809e-38
Cyclosporine	Atorvastatin	0.428	-2.633	Major	125 (37/88)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#A8C8E1	13.0550075353503	3.20038970563088e-17
Propranolol	Ergotamine	0.296	4.271	Moderate	63 (52/11)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#EDA3A3	6.57972379781658	0.000109932035904646
Ergotamine	Rizatriptan	0.284	3.614	Major	55 (44/11)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F0A7A7	5.74420331555415	1.9718371293826e-10
Dextromethorphan	Paroxetine	0.169	3.8	Major	328 (265/63)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F0A7A7	34.2563397727593	1
Sumatriptan	Paroxetine	0.257	7.453	Major	148 (132/16)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#E28989	15.4571289218548	1
Alprazolam	Itraconazole	0.17	3.447	Major	313 (248/65)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F0A9A9	32.6897388685173	1
Methotrexate	Acetylsalicylic acid	0.271	-1.156	Major	229 (112/117)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B4D1E6	23.9167738047618	1
Duloxetine	Ciprofloxacin	0.13	2.732	Major	330 (248/82)		#F3AFAF	34.4652198933249	1
Tramadol	Carbamazepine	0.294	1.46	Moderate	225 (139/86)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F7B9B9	23.4990135636306	1
Venlafaxine	Almotriptan	0.194	9.808	Major	83 (76/7)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#DA7878	8.66852500347263	1
Methotrexate	Diclofenac	0.2	1.514	Major	388 (243/145)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F7B9B9	40.5227433897275	1
Fluconazole	Diazepam	0.274	2.571	Moderate	500 (370/130)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F4B1B1	52.2200301414014	1
Phenytoin	Dexamethasone	0.347	-1.515	Moderate	45 (19/26)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#B1CFE5	4.69980271272613	2.53471599484408e-11
Risperidone	Donepezil	0.205	1.355	Moderate	10 (6/4)		#F8BABA	1.04440060282803	2.55315480751506e-05
Ezetimibe	Cholestyramine	0.232	-2.275	Moderate	55 (18/37)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#ABCBE2	5.74420331555415	8.00246283145976e-18
Enalapril	Tizanidine	0.144	-1.095	Major	354 (178/176)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#B4D1E6	36.9717813401122	1
Clozapine	Clonazepam	0.314	-1.61	Moderate	27 (11/16)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#AFCEE4	2.81988162763568	6.00993923203161e-14
Ramipril	Spironolactone	0.399	-4.206	Major	192 (40/152)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#9CBFDB	20.0524915742981	6.82592746373541e-21
Carbamazepine	Sertraline	0.341	1.345	Moderate	112 (67/45)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F8BABA	11.6972867516739	1
Phenytoin	Topiramate	0.519	-1.684	Moderate	58 (23/35)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#AFCEE4	6.05752349640256	7.07666309490373e-17
Fluoxetine	Ergotamine	0.246	4.517	Major	102 (85/17)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#EDA1A1	10.6528861488459	1
Alprazolam	Carbamazepine	0.246	1.377	Moderate	207 (125/82)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F8BABA	21.6190924785402	1
Spironolactone	Tolevamer	0.278	-3.321	Moderate	28 (7/21)		#A3C5DF	2.92432168791848	2.03246163444806e-15
Fluoxetine	Oxycodone	0.219	3.423	Moderate	91 (72/19)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F0A9A9	9.50404548573505	1
Almotriptan	Escitalopram	0.237	6.504	Major	82 (72/10)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#E69191	8.56408494318983	1
Digoxin	Propafenone	0.391	-2.214	Moderate	12 (4/8)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#ABCBE2	1.25328072339363	3.76638448291916e-08
Fluoxetine	Lithium cation	0.355	1.121	Major	130 (72/58)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	13.5772078367644	0.0724853217445423
Ibuprofen	Nadolol	0.22	2.664	Moderate	233 (174/59)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F3AFAF	24.3345340458931	1
Cyclosporine	Methotrexate	0.232	1.042	Moderate	28 (15/13)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#F9BCBC	2.92432168791848	1.50391779359398e-07
Cyclosporine	Sulfadiazine	0.5	Inf	Major	1 (1/0)	Sulfadiazine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.104440060282803	1
Fluoxetine	Acenocoumarol	0.322	1.169	None	156 (88/68)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F9BCBC	16.2926494041172	1
Bisoprolol	Glyburide	0.295	-3.246	Moderate	232 (59/173)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#A3C5DF	24.2300939856102	1
Citalopram	Sumatriptan	0.224	5.033	Major	138 (117/21)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#EB9C9C	14.4127283190268	1
Simvastatin	Itraconazole	0.123	-1.127	Major	442 (219/223)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#B4D1E6	46.1625066449988	1
Verapamil	Atorvastatin	0.391	-2.131	Moderate	117 (40/77)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#ACCCE3	12.2194870530879	0.358243157150279
Ranolazine	Verapamil	0.119	Inf	Major	3 (3/0)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B32020	0.313320180848408	1
Fluoxetine	Nortriptyline	0.377	2.065	Major	46 (32/14)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F5B4B4	4.80424277300893	3.3302873894408e-08
Salbutamol	Clomipramine	0.153	1.904	Moderate	202 (137/65)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F6B6B6	21.0968921771262	1
Galantamine	Quetiapine	0.346	1.205	Moderate	7 (4/3)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#F8BABA	0.73108042197962	0.000505577942761159
Spironolactone	Telmisartan	0.43	-1.492	Major	54 (23/31)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#B1CFE5	5.63976325527135	0.0164349091080719
Glimepiride	Repaglinide	0.243	-2.451	None	45 (14/31)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#A9C9E1	4.69980271272613	7.56688499352095e-09
Fluvoxamine	Lithium cation	0.43	-1.022	Major	25 (13/12)	Lithium may increase the serotonergic activities of Fluvoxamine.	#B4D1E6	2.61100150707007	1.72214529406109e-08
Fluvoxamine	Mirtazapine	0.306	1.092	Major	53 (29/24)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F9BCBC	5.53532319498855	2.26511158151666e-06
Aprepitant	Dexamethasone	0.077	Inf	Moderate	1 (1/0)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#B32020	0.104440060282803	1
Rivastigmine	Quetiapine	0.264	-1.107	Moderate	10 (5/5)		#B4D1E6	1.04440060282803	1.53148793075974e-05
Omeprazole	Cilostazol	0.283	-4.428	Major	340 (68/272)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#9ABEDB	35.5096204961529	1
Prazosin	Propranolol	0.365	-1.384	Moderate	9 (4/5)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#B2D0E5	0.939960542545225	1.66753435675783e-07
Warfarin	Azathioprine	0.291	2.409	Moderate	11 (8/3)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F4B1B1	1.14884066311083	0.176237792094179
Methimazole	Acenocoumarol	0.307	1.027	None	47 (25/22)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F9BCBC	4.90868283329173	0.000699597600415517
Atorvastatin	Clarithromycin	0.117	-1.443	Major	486 (211/275)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B1CFE5	50.7578692974422	1
Indomethacin	Alendronic acid	0.244	4.623	Moderate	104 (87/17)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#EC9F9F	10.8617662694115	1
Bisoprolol	Repaglinide	0.292	-3.953	Moderate	192 (42/150)		#9FC1DD	20.0524915742981	1.07499162203464e-05
Glimepiride	Gemfibrozil	0.271	-6.642	Moderate	168 (24/144)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#89B1D3	17.5459301275109	2.56260180852062e-25
Citalopram	Almotriptan	0.248	5.976	Major	99 (86/13)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#E89696	10.3395659679975	1
Imipramine	Duloxetine	0.301	2.811	Major	37 (28/9)	Duloxetine may increase the serotonergic activities of Imipramine.	#F2AEAE	3.8642822304637	0.000295007027029527
Phenytoin	Quetiapine	0.389	-1.693	Major	43 (17/26)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#AFCEE4	4.49092259216052	2.39706937218419e-07
Pravastatin	Gemfibrozil	0.311	-3.149	Major	173 (45/128)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#A5C6DF	18.0681304289249	1
Folic acid	Phenytoin	0.344	-1.792	Moderate	55 (21/34)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#AFCEE4	5.74420331555415	3.67519125204591e-08
Folic acid	Phenobarbital	0.284	-1.753	Moderate	62 (24/38)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#AFCEE4	6.47528373753377	4.77030476381776e-10
Diltiazem	Amlodipine	0.378	-2.961	Moderate	147 (40/107)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#A6C7E0	15.352688861572	1
Warfarin	Acetylsalicylic acid	0.263	-3.588	Major	123 (29/94)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#A2C4DE	12.8461274147847	7.94378586667808e-08
Acetylsalicylic acid	Methylprednisolone	0.23	-1.293	Moderate	219 (101/118)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#B2D0E5	22.8723732019338	1
Acitretin	Methotrexate	0.125	1.016	Major	17 (9/8)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#F9BCBC	1.77548102480765	1.04155318480102e-05
Fluconazole	Fentanyl	0.328	-1.328	Major	132 (60/72)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B2D0E5	13.78608795733	0.342660126841281
Atenolol	Repaglinide	0.328	-1.76	Moderate	101 (39/62)		#AFCEE4	10.5484460885631	1
Erythromycin	Simvastatin	0.107	1.205	Major	259 (148/111)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F8BABA	27.0499756132459	1
Fenofibrate	Fluvastatin	0.45	-3.572	Major	93 (22/71)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#A2C4DE	9.71292560630066	4.69892352505084e-09
Duloxetine	Nortriptyline	0.232	3.614	Major	25 (20/5)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F0A7A7	2.61100150707007	0.000530620190178583
Fluoxetine	Sumatriptan	0.248	6.046	Major	100 (87/13)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#E79494	10.4440060282803	1
Fluoxetine	Almotriptan	0.211	7.127	Major	80 (71/9)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#E38D8D	8.35520482262422	1
Simvastatin	Colchicine	0.206	-7.585	Major	479 (61/418)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#83ADD1	50.0267888754625	1
Buspirone	Rifampicin	0.267	Inf	Major	1 (1/0)	The serum concentration of Buspirone can be decreased when it is combined with Rifampicin.	#B32020	0.104440060282803	1
Bisoprolol	Insulin detemir	0.318	-2.11	Moderate	93 (32/61)		#ACCCE3	9.71292560630066	1
Paroxetine	Almotriptan	0.212	5.033	Major	92 (78/14)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#EB9C9C	9.60848554601786	1
Repaglinide	Carvedilol	0.344	-4.723	Moderate	79 (15/64)		#99BDDA	8.25076476234142	4.39958274237425e-17
Phenytoin	Diazepam	0.347	-1.577	Moderate	160 (66/94)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#B1CFE5	16.7104096452484	1
Trazodone	Donepezil	0.257	2.409	Moderate	11 (8/3)		#F4B1B1	1.14884066311083	0.00352286919079362
Bisoprolol	Salmeterol	0.261	-1.783	Moderate	248 (95/153)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#AFCEE4	25.9011349501351	1
Amiodarone	Flecainide	0.159	-4.059	Major	28 (6/22)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#9DC0DC	2.92432168791848	6.33324421240295e-11
Diazepam	Itraconazole	0.279	2.062	Moderate	325 (226/99)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F5B4B4	33.9430195919109	1
Fluoxetine	Carbamazepine	0.293	1.538	Moderate	100 (63/37)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F7B9B9	10.4440060282803	1
Fluconazole	Clonazepam	0.168	2.049	None	134 (93/41)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F5B4B4	13.9949680778956	1
Cyclosporine	Ezetimibe	0.377	-1.55	Moderate	24 (10/14)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#B1CFE5	2.50656144678727	0.00727851811173452
Fluoxetine	Carvedilol	0.348	-1.165	Moderate	117 (57/60)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#B4D1E6	12.2194870530879	1
Diclofenac	Lithium cation	0.114	1.283	Moderate	196 (115/81)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F8BABA	20.4702518154293	1
Sertraline	Carvedilol	0.346	-1.66	Moderate	115 (46/69)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#AFCEE4	12.0106069325223	1
Atomoxetine	Propafenone	1	Inf	Moderate	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Propafenone.	#B32020	0.104440060282803	1
Sumatriptan	Escitalopram	0.238	5.962	Major	76 (66/10)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#E89696	7.93744458149301	1
Ranolazine	Sotalol	0.136	-1.107	Major	2 (1/1)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.208880120565606	1
Hydrocortisone	Acetylsalicylic acid	0.238	-1.629	Moderate	220 (89/131)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#AFCEE4	22.9768132622166	1
Paroxetine	Carvedilol	0.325	-1.589	Moderate	151 (62/89)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#B1CFE5	15.7704491027032	1
Cyclosporine	Simvastatin	0.329	-1.535	Major	105 (44/61)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	10.9662063296943	1
Fenofibrate	Ursodeoxycholic acid	0.392	-1.059	None	45 (23/22)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#B4D1E6	4.69980271272613	1
Citalopram	Oxycodone	0.242	1.869	Moderate	89 (60/29)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F6B6B6	9.29516536516945	1
Atenolol	Formoterol	0.189	-1.069	Moderate	230 (117/113)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B4D1E6	24.0212138650446	1
Azathioprine	Acenocoumarol	0.372	-1.314	None	35 (16/19)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#B2D0E5	3.6554021098981	0.46312465488167
Oxycodone	Sertraline	0.209	2.371	Moderate	58 (42/16)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F5B2B2	6.05752349640256	1
Ethinylestradiol	Amoxicillin	0.232	41.556	Moderate	141 (138/3)		#B32020	14.7260484998752	1
Fluconazole	Atorvastatin	0.152	-1.6	Major	269 (110/159)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B1CFE5	28.094376216074	1
Metformin	Glucosamine	0.181	-1.275	None	241 (112/129)		#B2D0E5	25.1700545281555	1
Nortriptyline	Moclobemide	0.235	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Nortriptyline.	#B32020	0.104440060282803	1
Prednisone	Estradiol	0.156	40.05	Moderate	136 (133/3)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	14.2038481984612	1
Paroxetine	Acenocoumarol	0.286	-1.245	None	153 (72/81)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	15.9793292232688	1
Ciprofloxacin	Acenocoumarol	0.108	-2.573	None	246 (74/172)		#A9C9E1	25.6922548295695	1
Gemfibrozil	Acenocoumarol	0.271	-4.008	None	134 (29/105)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#9DC0DC	13.9949680778956	1
Cyclosporine	Ticlopidine	0.771	-1.107	Moderate	2 (1/1)	The metabolism of Cyclosporine can be decreased when combined with Ticlopidine.	#B4D1E6	0.208880120565606	1
Fluconazole	Amitriptyline	0.176	3.02	Moderate	152 (117/35)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F2ACAC	15.874889162986	1
Propranolol	Salbutamol	0.164	1.077	Major	263 (143/120)		#F9BCBC	27.4677358543771	1
Fluvoxamine	Duloxetine	0.285	2.61	Major	35 (26/9)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F3AFAF	3.6554021098981	1
Pentoxifylline	Acenocoumarol	0.365	-3.013	None	67 (18/49)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#A5C6DF	6.99748403894779	0.000351218450179345
Levothyroxine	Cholestyramine	0.182	6.324	Moderate	56 (49/7)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#E69393	5.84864337583696	1
Gliclazide	Carvedilol	0.316	-5.535	None	138 (23/115)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#93B8D7	14.4127283190268	2.72351959983131e-07
Eletriptan	Paroxetine	0.304	12.045	Major	43 (40/3)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#D26565	4.49092259216052	1
Spironolactone	Cholestyramine	0.207	-2.767	Moderate	35 (10/25)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#A8C8E1	3.6554021098981	1.22903450789882e-09
Oxycodone	Escitalopram	0.232	1.39	Moderate	66 (40/26)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F8BABA	6.89304397866498	1
Imipramine	Fluoxetine	0.39	2.085	Major	43 (30/13)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F5B4B4	4.49092259216052	1
Salbutamol	Carvedilol	0.139	-2.116	Major	198 (68/130)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#ACCCE3	20.679131935995	1
Acetylsalicylic acid	Dexamethasone	0.245	-1.799	Moderate	189 (72/117)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#AFCEE4	19.7391713934497	1
Indomethacin	Atenolol	0.182	-1.781	Moderate	167 (64/103)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#AFCEE4	17.4414900672281	1
Citalopram	Carvedilol	0.359	-2.097	Moderate	165 (57/108)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#ACCCE3	17.2326099466625	1
Fluvoxamine	Methadone	0.185	Inf	Moderate	2 (2/0)	The metabolism of Methadone can be decreased when combined with Fluvoxamine.	#B32020	0.208880120565606	1
Cyclosporine	Fluvastatin	0.564	1.807	Moderate	9 (6/3)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#F6B6B6	0.939960542545225	1
Rosuvastatin	Gemfibrozil	0.318	-3.281	Major	111 (28/83)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#A3C5DF	11.5928466913911	1
Eletriptan	Venlafaxine	0.259	8.432	Major	31 (28/3)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#DF8181	3.23764186876689	1
Trospium	Doxepin	0.091	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Simvastatin	Amiodarone	0.32	-4.788	Major	229 (43/186)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#99BDDA	23.9167738047618	1
Enalapril	Lithium cation	0.314	-1.283	Moderate	149 (69/80)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#B2D0E5	15.5615689821376	1
Zolmitriptan	Dihydroergotamine	0.293	2.452	Major	26 (19/7)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F4B1B1	2.71544156735287	0.0206336480401185
Repaglinide	Gemfibrozil	0.256	-3.985	Major	92 (20/72)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#9FC1DD	9.60848554601786	1
Fluvoxamine	Carbamazepine	0.379	3.011	Moderate	13 (10/3)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#F2ACAC	1.35772078367644	1
Atenolol	Ergotamine	0.216	2.785	Moderate	49 (37/12)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F3AFAF	5.11756295385734	1
Spironolactone	Eplerenone	0.098	-8.634	Major	44 (5/39)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#7AA6CD	4.59536265244332	2.15325156362849e-15
Omeprazole	Triazolam	0.214	1.42	Moderate	54 (33/21)		#F7B9B9	5.63976325527135	1
Indomethacin	Losartan	0.167	-1.915	Moderate	172 (63/109)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#AECDE3	17.9636903686421	1
Ergotamine	Almotriptan	0.236	7.679	Major	19 (17/2)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#E18888	1.98436114537325	0.638753420999267
Gentamicin	Cefonicid	1	-1.107	Moderate	2 (1/1)		#B4D1E6	0.208880120565606	1
Trospium	Donepezil	0.8	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#B32020	0.104440060282803	1
Carvedilol	Escitalopram	0.404	-1.788	None	102 (39/63)		#AFCEE4	10.6528861488459	1
Atorvastatin	Colchicine	0.206	-9.111	Major	240 (26/214)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#77A4CB	25.0656144678727	1
Pregabalin	Pioglitazone	0.254	-1.153	Moderate	49 (24/25)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#B4D1E6	5.11756295385734	1
Almotriptan	Sertraline	0.245	6.625	Major	50 (44/6)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#E59090	5.22200301414014	1
Dihydroergotamine	Rizatriptan	0.388	4.065	Major	22 (18/4)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#EEA4A4	2.29768132622166	0.622144913337765
Phenytoin	Gabapentin	0.422	-1.476	Moderate	49 (21/28)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B1CFE5	5.11756295385734	1
Levofloxacin	Acenocoumarol	0.126	-2.237	None	142 (47/95)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	14.830488560158	1
Digoxin	Hydrochlorothiazide	0.354	-1.718	Moderate	74 (29/45)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#AFCEE4	7.72856446092741	1
Eletriptan	Escitalopram	0.264	8.131	Major	30 (27/3)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#E08585	3.13320180848408	1
Dihydroergotamine	Propranolol	0.28	3.794	Moderate	26 (21/5)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F0A7A7	2.71544156735287	1
Naproxen	Lithium cation	0.114	1.326	Major	153 (91/62)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F8BABA	15.9793292232688	1
Cyclosporine	Pravastatin	0.437	-2.989	Major	37 (10/27)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#A6C7E0	3.8642822304637	4.72397630962222e-08
Digoxin	Levothyroxine	0.359	1.205	Moderate	63 (36/27)		#F8BABA	6.57972379781658	1
Ranolazine	Simvastatin	0.305	-1.693	Major	43 (17/26)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#AFCEE4	4.49092259216052	1
Carbamazepine	Doxepin	0.183	Inf	Moderate	3 (3/0)	The metabolism of Doxepin can be increased when combined with Carbamazepine.	#B32020	0.313320180848408	1
Doxycycline	Amoxicillin	0.482	1.276	Moderate	316 (185/131)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#F8BABA	33.0030590493657	1
Olanzapine	Donepezil	0.196	3.614	Moderate	5 (4/1)		#F0A7A7	0.522200301414014	1
Pimozide	Escitalopram	0.291	2.71	Major	12 (9/3)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#F3AFAF	1.25328072339363	0.840984838304865
Phenytoin	Vigabatrin	0.096	-1.107	Minor	2 (1/1)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B4D1E6	0.208880120565606	1
Haloperidol	Propranolol	0.314	-1.398	Moderate	43 (19/24)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#B2D0E5	4.49092259216052	0.693649640450842
Prazosin	Nadolol	0.48	-6.642	Moderate	7 (1/6)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#89B1D3	0.73108042197962	2.08620981826156e-10
Cyclosporine	Danazol	0.5	Inf	Moderate	1 (1/0)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#B32020	0.104440060282803	1
Valproic acid	Nimodipine	0.471	1.445	Minor	13 (8/5)		#F7B9B9	1.35772078367644	1
Citalopram	Eletriptan	0.237	Inf	Major	36 (36/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#B32020	3.7598421701809	1
Glyburide	Carvedilol	0.273	-4.428	Moderate	70 (14/56)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#9ABEDB	7.3108042197962	0.000335284555253309
Trazodone	Acenocoumarol	0.215	-1.607	None	76 (31/45)		#AFCEE4	7.93744458149301	1
Bisoprolol	Verapamil	0.273	-1.328	Major	44 (20/24)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B2D0E5	4.59536265244332	1
Ranitidine	Acenocoumarol	0.319	-2.504	None	137 (42/95)		#A9C9E1	14.308288258744	1
Levothyroxine	Warfarin	0.27	1.474	Moderate	50 (31/19)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F7B9B9	5.22200301414014	1
Acetaminophen	Isoniazid	0.234	-1.307	Moderate	181 (83/98)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B2D0E5	18.9036509111873	1
Metoprolol	Ibuprofen	0.142	1.091	Moderate	117 (64/53)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	12.2194870530879	1
Carvedilol	Insulin detemir	0.294	-4.428	Moderate	45 (9/36)		#9ABEDB	4.69980271272613	1.24335071880055e-08
Dihydroergotamine	Fluoxetine	0.244	6.504	Major	41 (36/5)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#E69191	4.28204247159491	1
Phenytoin	Ciprofloxacin	0.08	-1.502	Moderate	66 (28/38)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#B1CFE5	6.89304397866498	1
Salmeterol	Carvedilol	0.26	-2.542	Major	89 (27/62)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#A9C9E1	9.29516536516945	1
Erythromycin	Diazepam	0.281	2.241	Moderate	181 (129/52)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F5B2B2	18.9036509111873	1
Fluvoxamine	Imipramine	0.338	1.129	Major	9 (5/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#F9BCBC	0.939960542545225	0.0144833955003002
Ergotamine	Nadolol	0.227	3.011	Moderate	13 (10/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F2ACAC	1.35772078367644	0.713254233770087
Cyclosporine	Nifedipine	0.368	-4.206	Moderate	24 (5/19)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#9CBFDB	2.50656144678727	1.10709144162086e-11
Ciprofloxacin	Methotrexate	0.126	1.712	Moderate	110 (72/38)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F7B7B7	11.4884066311083	1
Prednisone	Phenobarbital	0.156	-1.015	Moderate	69 (36/33)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	7.20636415951339	1
Lorazepam	Phenytoin	0.348	-1.937	Moderate	110 (40/70)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#AECDE3	11.4884066311083	1
Ciprofloxacin	Sevelamer	0.165	-1.384	Moderate	36 (16/20)		#B2D0E5	3.7598421701809	1
Eletriptan	Fluoxetine	0.192	Inf	Major	30 (30/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	3.13320180848408	1
Erythromycin	Citalopram	0.116	3.471	Major	92 (73/19)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F0A9A9	9.60848554601786	1
Oxycodone	Paroxetine	0.24	1.936	Moderate	66 (45/21)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F6B6B6	6.89304397866498	1
Amitriptyline	Terbutaline	0.137	5.947	Moderate	91 (79/12)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#E89696	9.50404548573505	1
Torasemide	Amikacin	0.071	Inf	Major	1 (1/0)	The serum concentration of Amikacin can be increased when it is combined with Torasemide.	#B32020	0.104440060282803	1
Pimozide	Sertraline	0.348	2.409	Major	11 (8/3)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#F4B1B1	1.14884066311083	1
Phenytoin	Megestrol acetate	0.374	-1.476	Moderate	7 (3/4)		#B1CFE5	0.73108042197962	0.800751448586859
Cyclosporine	Rifampicin	0.174	2.71	Major	4 (3/1)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#F3AFAF	0.417760241131211	1
Phenytoin	Furosemide	0.36	-1.788	Minor	34 (13/21)	Phenytoin may decrease the diuretic activities of Furosemide.	#AFCEE4	3.5509620496153	1
Indomethacin	Furosemide	0.298	-1.339	Moderate	95 (43/52)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B2D0E5	9.92180572686627	1
Atorvastatin	Bezafibrate	0.371	-2.398	None	38 (12/26)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#ABCBE2	3.96872229074651	1
Azithromycin	Acenocoumarol	0.107	-1.636	None	166 (67/99)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#AFCEE4	17.3370500069453	1
Methylprednisolone	Clarithromycin	0.588	1.757	Major	106 (70/36)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F7B7B7	11.0706463899771	1
Lamotrigine	Norethisterone	0.195	23.488	Moderate	27 (26/1)		#B32020	2.81988162763568	1
Omeprazole	Ketoconazole	0.252	1.091	Moderate	117 (64/53)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#F9BCBC	12.2194870530879	1
Warfarin	Methimazole	0.284	1.807	Moderate	9 (6/3)	Methimazole may decrease the anticoagulant activities of Warfarin.	#F6B6B6	0.939960542545225	1
Atenolol	Insulin detemir	0.283	-1.937	Moderate	55 (20/35)		#AECDE3	5.74420331555415	1
Ciprofloxacin	Iron	0.44	2.395	Moderate	157 (114/43)		#F5B2B2	16.3970894644	1
Formoterol	Carvedilol	0.243	-2.65	Major	112 (33/79)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#A8C8E1	11.6972867516739	1
Diltiazem	Buspirone	0.5	Inf	Moderate	1 (1/0)	The metabolism of Buspirone can be decreased when combined with Diltiazem.	#B32020	0.104440060282803	1
Diltiazem	Cilostazol	0.526	-2.952	Major	11 (3/8)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#A6C7E0	1.14884066311083	1
Nabumetone	Methotrexate	0.182	3.614	Major	15 (12/3)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#F0A7A7	1.56660090424204	1
Digoxin	Telithromycin	0.143	Inf	Moderate	1 (1/0)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#B32020	0.104440060282803	1
Glimepiride	Pregabalin	0.196	-1.181	None	62 (30/32)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B4D1E6	6.47528373753377	1
Indomethacin	Propranolol	0.213	1.957	Moderate	57 (39/18)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F6B6B6	5.95308343611976	1
Haloperidol	Rifabutin	0.167	Inf	None	1 (1/0)	The metabolism of Haloperidol can be increased when combined with Rifabutin.	#B32020	0.104440060282803	1
Cyclosporine	Ciprofloxacin	0.168	-1.459	Moderate	51 (22/29)		#B1CFE5	5.32644307442294	1
Ziprasidone	Carbamazepine	0.358	-2.878	Minor	18 (5/13)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#A6C7E0	1.87992108509045	8.49279120784486e-08
Acetylsalicylic acid	Ginkgo biloba	0.296	-1.365	Moderate	67 (30/37)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#B2D0E5	6.99748403894779	1
Galantamine	Methotrimeprazine	0.125	Inf	Moderate	1 (1/0)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#B32020	0.104440060282803	1
Bisoprolol	Terbutaline	0.164	-1.044	Moderate	103 (53/50)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	10.7573262091287	1
Propranolol	Salmeterol	0.23	1.299	Major	78 (46/32)		#F8BABA	8.14632470205862	1
Paroxetine	Frovatriptan	0.243	Inf	None	21 (21/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#B32020	2.19324126593886	1
Atenolol	Salmeterol	0.218	-1.515	Moderate	135 (57/78)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#B1CFE5	14.0994081381784	1
Propranolol	Phenobarbital	0.283	-1.107	Moderate	26 (13/13)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#B4D1E6	2.71544156735287	1
Fluvoxamine	Tramadol	0.209	2.008	Major	58 (40/18)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F5B4B4	6.05752349640256	1
Sucralfate	Levothyroxine	0.167	5.307	Minor	55 (47/8)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#EA9B9B	5.74420331555415	1
Spironolactone	Perindopril	0.315	-2.029	Major	17 (6/11)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#ACCCE3	1.77548102480765	1
Fenofibrate	Acenocoumarol	0.327	-7.441	None	139 (18/121)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#83ADD1	14.5171683793096	1
Carbamazepine	Acenocoumarol	0.284	-1.703	None	33 (13/20)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#AFCEE4	3.44652198933249	1
Fluoxetine	Naratriptan	0.285	4.969	Major	13 (11/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#EB9E9E	1.35772078367644	1
Mirtazapine	Donepezil	0.254	2.258	Moderate	7 (5/2)		#F5B2B2	0.73108042197962	1
Digoxin	Alprazolam	0.29	-1.513	Moderate	71 (30/41)		#B1CFE5	7.415244280079	1
Megestrol acetate	Phenobarbital	0.207	-1.845	Moderate	8 (3/5)		#AECDE3	0.835520482262422	0.240153460187771
Prednisone	Warfarin	0.214	-1.396	Moderate	52 (23/29)	Prednisone may increase the anticoagulant activities of Warfarin.	#B2D0E5	5.43088313470575	1
Erythromycin	Fluoxetine	0.162	5.42	Moderate	63 (54/9)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#E99999	6.57972379781658	1
Digoxin	Telmisartan	0.312	-3.69	Moderate	26 (6/20)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#A0C3DD	2.71544156735287	0.00046888364769292
Theophylline	Clarithromycin	0.643	2.71	Moderate	24 (18/6)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#F3AFAF	2.50656144678727	1
Frovatriptan	Escitalopram	0.234	Inf	Major	15 (15/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#B32020	1.56660090424204	1
Warfarin	Ibuprofen	0.171	-1.409	Major	125 (55/70)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B1CFE5	13.0550075353503	1
Phenytoin	Alprazolam	0.315	-1.66	Moderate	75 (30/45)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#AFCEE4	7.83300452121021	1
Warfarin	Pentoxifylline	0.258	-1.55	Moderate	12 (5/7)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#B1CFE5	1.25328072339363	1
Cimetidine	Carbamazepine	0.145	Inf	Moderate	2 (2/0)	The serum concentration of Carbamazepine can be increased when it is combined with Cimetidine.	#B32020	0.208880120565606	1
Digoxin	Diazepam	0.266	-1.466	Moderate	86 (37/49)		#B1CFE5	8.98184518432104	1
Erythromycin	Atorvastatin	0.084	-1.205	Major	94 (45/49)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#B2D0E5	9.81736566658346	1
Dihydroergotamine	Sumatriptan	0.405	2.484	Major	15 (11/4)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F4B1B1	1.56660090424204	1
Cyclosporine	Diltiazem	0.49	1.205	Moderate	7 (4/3)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#F8BABA	0.73108042197962	1
Rosiglitazone	Gemfibrozil	0.391	-4.206	Moderate	24 (5/19)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#9CBFDB	2.50656144678727	0.108765652816408
Propranolol	Formoterol	0.221	1.211	Major	103 (59/44)		#F8BABA	10.7573262091287	1
Moclobemide	Clomipramine	0.517	-1.66	None	5 (2/3)	Moclobemide may increase the serotonergic activities of Clomipramine.	#AFCEE4	0.522200301414014	0.030516899712217
Verapamil	Carvedilol	0.33	-2.214	Major	18 (6/12)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#ABCBE2	1.87992108509045	1
Escitalopram	Rasagiline	0.277	-1.66	Major	20 (8/12)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#AFCEE4	2.08880120565606	1
Indomethacin	Bisoprolol	0.15	-3.837	Moderate	201 (45/156)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#9FC1DD	20.9924521168434	1
Ziprasidone	Pimozide	0.337	-1.107	Major	2 (1/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#B4D1E6	0.208880120565606	1
Phenytoin	Hydrocortisone	0.252	-1.599	Moderate	22 (9/13)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#B1CFE5	2.29768132622166	1
Pioglitazone	Gemfibrozil	0.307	-6.365	Major	54 (8/46)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#8CB4D5	5.63976325527135	4.98829490303818e-05
Atenolol	Insulin aspart	0.325	-2.649	Moderate	95 (28/67)		#A8C8E1	9.92180572686627	1
Citalopram	Warfarin	0.321	-1.34	Moderate	42 (19/23)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#B2D0E5	4.38648253187772	1
Phenytoin	Cimetidine	0.333	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Cimetidine is combined with Phenytoin.	#B32020	0.104440060282803	1
Cyclosporine	Colchicine	0.114	-1.476	Major	7 (3/4)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#B1CFE5	0.73108042197962	1
Fluvastatin	Gemfibrozil	0.274	-3.661	Major	56 (13/43)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#A0C3DD	5.84864337583696	1
Eletriptan	Sertraline	0.229	Inf	Major	19 (19/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#B32020	1.98436114537325	1
Imipramine	Salbutamol	0.239	3.049	Moderate	35 (27/8)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F2ACAC	3.6554021098981	1
Terbutaline	Clomipramine	0.152	2.135	Moderate	37 (26/11)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F5B4B4	3.8642822304637	1
Pantoprazole	Itraconazole	0.294	1.061	Moderate	87 (47/40)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F9BCBC	9.08628524460384	1
Cyclosporine	Tacrolimus	0.142	-3.136	Major	23 (6/17)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#A5C6DF	2.40212138650446	0.000117177395972561
Hydrocortisone	Phenobarbital	0.072	2.258	Moderate	14 (10/4)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#F5B2B2	1.46216084395924	1
Spironolactone	Irbesartan	0.45	-4.428	Major	55 (11/44)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#9ABEDB	5.74420331555415	0.0147484843774568
Itraconazole	Budesonide	0.339	-1.006	Major	189 (99/90)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B4D1E6	19.7391713934497	1
Methotrexate	Phenylbutazone	0.374	-1.107	Major	4 (2/2)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#B4D1E6	0.417760241131211	1
Atenolol	Terbutaline	0.149	-1.058	Moderate	88 (45/43)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	9.19072530488665	1
Lidocaine	Propranolol	0.153	2.008	Moderate	29 (20/9)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F5B4B4	3.02876174820128	1
Tizanidine	Lisinopril	0.159	1.104	Major	60 (33/27)	Tizanidine may increase the hypotensive activities of Lisinopril.	#F9BCBC	6.26640361696817	1
Erythromycin	Methylprednisolone	0.664	2.968	Moderate	30 (23/7)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F2AEAE	3.13320180848408	1
Donepezil	Sertraline	0.358	1.807	Minor	9 (6/3)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F6B6B6	0.939960542545225	1
Verapamil	Eplerenone	0.345	-3.321	Moderate	8 (2/6)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#A3C5DF	0.835520482262422	1
Raloxifene	Estradiol	0.358	Inf	Moderate	23 (23/0)		#B32020	2.40212138650446	1
Eletriptan	Ergotamine	0.145	Inf	Major	7 (7/0)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#B32020	0.73108042197962	1
Prednisone	Rifampicin	0.333	-1.107	Moderate	44 (22/22)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#B4D1E6	4.59536265244332	1
Galantamine	Tolterodine	0.5	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#B32020	0.104440060282803	1
Sotalol	Ibuprofen	0.165	1.15	Moderate	50 (28/22)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#F9BCBC	5.22200301414014	1
Omeprazole	Quazepam	0.21	6.023	Moderate	23 (20/3)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#E79494	2.40212138650446	1
Ergotamine	Naratriptan	0.611	Inf	Major	3 (3/0)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.313320180848408	1
Clozapine	Lamotrigine	0.506	1.807	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#F6B6B6	0.313320180848408	1
Trospium	Quetiapine	0.258	2.258	Moderate	7 (5/2)		#F5B2B2	0.73108042197962	1
Atenolol	Diltiazem	0.363	-1.968	Major	50 (18/32)	Diltiazem may increase the hypotensive activities of Atenolol.	#AECDE3	5.22200301414014	1
Duloxetine	Flecainide	0.267	1.694	Moderate	23 (15/8)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#F7B7B7	2.40212138650446	1
Lorazepam	Clozapine	0.27	-1.308	Major	24 (11/13)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#B2D0E5	2.50656144678727	1
Bisoprolol	Ergotamine	0.276	2.053	Moderate	36 (25/11)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F5B4B4	3.7598421701809	1
Fluvastatin	Acenocoumarol	0.435	-4.182	None	43 (9/34)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#9DC0DC	4.49092259216052	0.110397043547247
Torasemide	Indomethacin	0.265	-1.15	Moderate	53 (26/27)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B4D1E6	5.53532319498855	1
Clonazepam	Itraconazole	0.152	2.058	None	59 (41/18)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F5B4B4	6.16196355668536	1
Rifabutin	Clarithromycin	0.595	-1.937	Moderate	11 (4/7)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#AECDE3	1.14884066311083	0.00505171255075913
Sertraline	Propafenone	0.233	2.033	Moderate	13 (9/4)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F5B4B4	1.35772078367644	1
Propranolol	Gliclazide	0.325	-1.7	None	71 (28/43)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	7.415244280079	1
Allopurinol	Warfarin	0.278	-8.634	Moderate	44 (5/39)	Allopurinol may increase the anticoagulant activities of Warfarin.	#7AA6CD	4.59536265244332	0.101734178682316
Sulfasalazine	Mercaptopurine	0.085	-2.214	Moderate	3 (1/2)		#ABCBE2	0.313320180848408	0.486567052394051
Prednisone	Ethinylestradiol	0.244	Inf	Moderate	35 (35/0)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	3.6554021098981	1
Losartan	Lithium cation	0.361	-1.423	Moderate	48 (21/27)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#B1CFE5	5.01312289357453	1
Sertraline	Rasagiline	0.421	-1.107	Major	14 (7/7)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	1.46216084395924	1
Propranolol	Propafenone	0.469	2.71	Moderate	8 (6/2)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F3AFAF	0.835520482262422	1
Clarithromycin	Quetiapine	0.181	1.842	Major	79 (53/26)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F6B6B6	8.25076476234142	1
Erythromycin	Sertraline	0.103	3.039	Moderate	48 (37/11)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F2ACAC	5.01312289357453	1
Norfloxacin	Acenocoumarol	0.119	1.286	None	63 (37/26)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	6.57972379781658	1
Phenytoin	Prednisone	0.12	-1.359	Moderate	49 (22/27)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B2D0E5	5.11756295385734	1
Disopyramide	Atenolol	0.219	-5.535	Major	6 (1/5)	Disopyramide may increase the bradycardic activities of Atenolol.	#93B8D7	0.626640361696817	0.00382717286531884
Ciprofloxacin	Warfarin	0.148	-1.693	Major	43 (17/26)		#AFCEE4	4.49092259216052	1
Lovastatin	Fenofibrate	0.297	1.016	Major	17 (9/8)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#F9BCBC	1.77548102480765	1
Amiodarone	Levofloxacin	0.217	-2.372	Major	44 (14/30)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#ABCBE2	4.59536265244332	1
Norfloxacin	Iron	0.42	5.797	None	89 (77/12)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#E89898	9.29516536516945	1
Phenytoin	Mirtazapine	0.324	-2.214	Moderate	30 (10/20)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#ABCBE2	3.13320180848408	1
Atenolol	Verapamil	0.259	-2.129	Major	38 (13/25)	Verapamil may increase the hypotensive activities of Atenolol.	#ACCCE3	3.96872229074651	1
Minocycline	Amoxicillin	0.346	1.319	Moderate	123 (73/50)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F8BABA	12.8461274147847	1
Hydrochlorothiazide	Lithium cation	0.248	-1.04	Major	64 (33/31)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B4D1E6	6.68416385809938	1
Carbamazepine	Norethisterone	0.198	17.164	Major	20 (19/1)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#C03E3E	2.08880120565606	1
Erythromycin	Levofloxacin	0.659	1.857	Moderate	55 (37/18)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F6B6B6	5.74420331555415	1
Venlafaxine	Frovatriptan	0.234	3.614	Major	15 (12/3)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#F0A7A7	1.56660090424204	1
Pyridostigmine	Fludrocortisone	0.438	-2.214	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#ABCBE2	0.313320180848408	0.24206708604067
Citalopram	Frovatriptan	0.255	15.358	Major	18 (17/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#C64C4C	1.87992108509045	1
Bisoprolol	Insulin glulisine	0.251	-3.723	Moderate	48 (11/37)		#A0C3DD	5.01312289357453	1
Phenytoin	Betamethasone	0.043	Inf	Moderate	4 (4/0)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#B32020	0.417760241131211	1
Chlorthalidone	Digoxin	0.326	Inf	Moderate	4 (4/0)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#B32020	0.417760241131211	1
Quinapril	Lithium cation	0.385	Inf	Moderate	3 (3/0)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#B32020	0.313320180848408	1
Propranolol	Glyburide	0.329	-1.353	Moderate	40 (18/22)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	4.17760241131211	1
Dihydroergotamine	Atenolol	0.191	2.065	Moderate	23 (16/7)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F5B4B4	2.40212138650446	1
Carbamazepine	Metronidazole	0.171	2.71	Moderate	28 (21/7)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F3AFAF	2.92432168791848	1
Thiethylperazine	Bromocriptine	0.078	Inf	Moderate	3 (3/0)		#B32020	0.313320180848408	1
Phenobarbital	Acenocoumarol	0.402	-2.583	None	20 (6/14)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#A9C9E1	2.08880120565606	1
Atomoxetine	Fluoxetine	0.422	2.258	Major	7 (5/2)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#F5B2B2	0.73108042197962	1
Methotrexate	Cloxacillin	0.096	1.581	Major	44 (28/16)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F7B9B9	4.59536265244332	1
Triamcinolone	Acetylsalicylic acid	0.146	-2.742	Moderate	153 (44/109)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#A8C8E1	15.9793292232688	1
Naproxen	Acenocoumarol	0.117	-1.237	None	144 (68/76)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	15.0393686807236	1
Methylergometrine	Nitroglycerin	1	1.205	Moderate	7 (4/3)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#F8BABA	0.73108042197962	1
Chlorpromazine	Propranolol	0.243	1.506	Moderate	8 (5/3)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#F7B9B9	0.835520482262422	1
Hydrocortisone	Acenocoumarol	0.153	-1.107	None	32 (16/16)		#B4D1E6	3.34208192904969	1
Nortriptyline	Epinephrine	0.422	Inf	Major	3 (3/0)	Nortriptyline may decrease the antihypertensive activities of Epinephrine.	#B32020	0.313320180848408	1
Lidocaine	Bisoprolol	0.135	-1.006	Moderate	42 (22/20)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#B4D1E6	4.38648253187772	1
Fluoxetine	Josamycin	0.164	7.679	None	19 (17/2)		#E18888	1.98436114537325	1
Alprazolam	Josamycin	0.163	1.957	None	38 (26/12)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F6B6B6	3.96872229074651	1
Trazodone	Ginkgo biloba	0.169	3.162	Moderate	18 (14/4)		#F2ACAC	1.87992108509045	1
Fluoxetine	Frovatriptan	0.314	6.324	Major	16 (14/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#E69393	1.67104096452484	1
Prednisone	Itraconazole	0.478	1.345	Moderate	117 (70/47)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F8BABA	12.2194870530879	1
Biperiden	Rivastigmine	0.186	-4.428	Moderate	5 (1/4)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#9ABEDB	0.522200301414014	0.00927860943570736
Fluvoxamine	Amitriptyline	0.22	4.065	Major	22 (18/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#EEA4A4	2.29768132622166	1
Bisoprolol	Epinephrine	0.099	1.024	Moderate	32 (17/15)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F9BCBC	3.34208192904969	1
Cyclosporine	Ibuprofen	0.161	-1.686	Moderate	111 (44/67)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#AFCEE4	11.5928466913911	1
Metronidazole	Phenobarbital	0.093	-1.015	Moderate	23 (12/11)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#B4D1E6	2.40212138650446	1
Cyclosporine	Fluconazole	0.316	-1.722	Moderate	23 (9/14)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#AFCEE4	2.40212138650446	1
Amitriptyline	Pseudoephedrine	0.222	7.378	None	55 (49/6)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#E38B8B	5.74420331555415	1
Propranolol	Maprotiline	0.216	5.42	Minor	7 (6/1)		#E99999	0.73108042197962	1
Estradiol	Phenobarbital	0.598	Inf	Moderate	9 (9/0)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#B32020	0.939960542545225	1
Rifampicin	Leflunomide	0.094	-1.845	Major	8 (3/5)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#AECDE3	0.835520482262422	0.792219222019816
Dihydroergotamine	Almotriptan	0.277	2.108	Major	10 (7/3)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#F5B4B4	1.04440060282803	1
Cloxacillin	Acenocoumarol	0.09	-2.566	None	73 (22/51)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#A9C9E1	7.6241244006446	1
Bisoprolol	Glipizide	0.32	-2.657	Moderate	17 (5/12)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#A8C8E1	1.77548102480765	1
Epinephrine	Clomipramine	0.281	2.71	Major	12 (9/3)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#F3AFAF	1.25328072339363	1
Trazodone	Itraconazole	0.19	4.517	Moderate	36 (30/6)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#EDA1A1	3.7598421701809	1
Sucralfate	Ibandronate	0.156	Inf	Moderate	8 (8/0)		#B32020	0.835520482262422	1
Methylprednisolone	Phenobarbital	0.159	2.409	Moderate	11 (8/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#F4B1B1	1.14884066311083	1
Metoprolol	Escitalopram	0.34	3.011	Minor	13 (10/3)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#F2ACAC	1.35772078367644	1
Paroxetine	Pimozide	0.345	2.108	Major	10 (7/3)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#F5B4B4	1.04440060282803	1
Repaglinide	Josamycin	0.251	3.614	None	5 (4/1)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#F0A7A7	0.522200301414014	1
Metoprolol	Fluoxetine	0.274	2.71	Moderate	16 (12/4)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F3AFAF	1.67104096452484	1
Erythromycin	Moxifloxacin	0.679	2.861	Major	25 (19/6)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F2AEAE	2.61100150707007	1
Ranitidine	Itraconazole	0.307	1.39	Moderate	66 (40/26)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F8BABA	6.89304397866498	1
Lidocaine	Labetalol	0.11	Inf	Moderate	2 (2/0)	The serum concentration of Lidocaine can be increased when it is combined with Labetalol.	#B32020	0.208880120565606	1
Cimetidine	Fentanyl	0.375	Inf	Moderate	2 (2/0)		#B32020	0.208880120565606	1
Trospium	Solifenacin	0.509	2.71	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#F3AFAF	0.417760241131211	1
Fluconazole	Imipramine	0.16	9.034	Moderate	11 (10/1)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#DC7D7D	1.14884066311083	1
Metronidazole	Lithium cation	0.102	1.92	Moderate	25 (17/8)		#F6B6B6	2.61100150707007	1
Labetalol	Ibuprofen	0.146	3.614	Moderate	25 (20/5)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#F0A7A7	2.61100150707007	1
Terbutaline	Carvedilol	0.09	-1.423	Major	32 (14/18)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#B1CFE5	3.34208192904969	1
Clarithromycin	Acenocoumarol	0.116	-1.393	None	70 (31/39)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B2D0E5	7.3108042197962	1
Fluoxetine	Propafenone	0.236	2.033	Moderate	13 (9/4)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F5B4B4	1.35772078367644	1
Ziprasidone	Chlorpromazine	0.185	-2.214	Major	3 (1/2)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#ABCBE2	0.313320180848408	1
Levofloxacin	Methotrimeprazine	0.144	-2.409	Moderate	54 (17/37)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#A9C9E1	5.63976325527135	1
Fluoxetine	Warfarin	0.182	1.205	Moderate	21 (12/9)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F8BABA	2.19324126593886	1
Simvastatin	Ketoconazole	0.083	1.355	Major	35 (21/14)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#F8BABA	3.6554021098981	1
Clonidine	Carvedilol	0.107	-1.107	Major	2 (1/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B4D1E6	0.208880120565606	1
Atorvastatin	Itraconazole	0.104	-2.349	Major	128 (41/87)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#ABCBE2	13.3683277161988	1
Lovastatin	Gemfibrozil	0.301	-1.66	Major	20 (8/12)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#AFCEE4	2.08880120565606	1
Clozapine	Diazepam	0.44	-1.771	Major	26 (10/16)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#AFCEE4	2.71544156735287	1
Fluconazole	Carbamazepine	0.16	1.28	Moderate	29 (17/12)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F8BABA	3.02876174820128	1
Trimethoprim	Methotrexate	0.177	1.957	Major	19 (13/6)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F6B6B6	1.98436114537325	1
Galantamine	Solifenacin	0.6	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#B32020	0.104440060282803	1
Cyclosporine	Azithromycin	0.144	-1.758	Moderate	44 (17/27)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#AFCEE4	4.59536265244332	1
Moxifloxacin	Acenocoumarol	0.085	-1.739	None	36 (14/22)		#AFCEE4	3.7598421701809	1
Ticlopidine	Acetylsalicylic acid	0.239	-1.476	Moderate	7 (3/4)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#B1CFE5	0.73108042197962	1
Lovastatin	Diltiazem	0.521	1.807	Major	6 (4/2)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#F6B6B6	0.626640361696817	1
Erythromycin	Acenocoumarol	0.088	-1.107	None	24 (12/12)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B4D1E6	2.50656144678727	1
Gemfibrozil	Ursodeoxycholic acid	0.354	-1.912	None	30 (11/19)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#AECDE3	3.13320180848408	1
Alprazolam	Ketoconazole	0.137	1.643	Major	31 (20/11)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F7B7B7	3.23764186876689	1
Digoxin	Methimazole	0.427	-2.491	Moderate	13 (4/9)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#A9C9E1	1.35772078367644	0.564646687647335
Rabeprazole	Itraconazole	0.11	2.484	Moderate	30 (22/8)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F4B1B1	3.13320180848408	1
Trospium	Olanzapine	0.301	Inf	Moderate	3 (3/0)		#B32020	0.313320180848408	1
Lidocaine	Atenolol	0.165	2.323	Moderate	25 (18/7)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F5B2B2	2.61100150707007	1
Clozapine	Sertraline	0.524	-1.66	Major	10 (4/6)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#AFCEE4	1.04440060282803	1
Paroxetine	Naratriptan	0.181	Inf	Major	8 (8/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B32020	0.835520482262422	1
Leflunomide	Acenocoumarol	0.169	5.42	None	7 (6/1)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#E99999	0.73108042197962	1
Atorvastatin	Fusidic acid	0.142	-1.028	None	27 (14/13)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	2.81988162763568	1
Carbamazepine	Oxybutynin	0.338	-1.384	None	9 (4/5)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#B2D0E5	0.939960542545225	1
Betamethasone	Primidone	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Betamethasone can be decreased when it is combined with Primidone.	#B32020	0.104440060282803	1
Cimetidine	Clonazepam	0.106	Inf	Moderate	3 (3/0)		#B32020	0.313320180848408	1
Nabumetone	Acenocoumarol	0.157	1.807	None	9 (6/3)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F6B6B6	0.939960542545225	1
Levofloxacin	Iron	0.411	1.771	Moderate	74 (49/25)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#F7B7B7	7.72856446092741	1
Digoxin	Rabeprazole	0.331	1.807	Moderate	9 (6/3)		#F6B6B6	0.939960542545225	1
Digoxin	Methotrexate	0.241	2.258	Moderate	7 (5/2)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F5B2B2	0.73108042197962	1
Citalopram	Naratriptan	0.263	7.227	Major	9 (8/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#E38B8B	0.939960542545225	1
Irbesartan	Lithium cation	0.363	-1.107	Moderate	14 (7/7)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#B4D1E6	1.46216084395924	1
Trospium	Tolterodine	0.054	1.807	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#F6B6B6	0.313320180848408	1
Theophylline	Ciprofloxacin	0.317	1.174	Major	23 (13/10)		#F9BCBC	2.40212138650446	1
Pseudoephedrine	Clomipramine	0.136	3.839	None	21 (17/4)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#EFA6A6	2.19324126593886	1
Phenytoin	Methylprednisolone	0.192	1.807	Moderate	9 (6/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#F6B6B6	0.939960542545225	1
Nortriptyline	Carbamazepine	0.403	1.355	Moderate	5 (3/2)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#F8BABA	0.522200301414014	1
Indomethacin	Acenocoumarol	0.13	-1.107	None	28 (14/14)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	2.92432168791848	1
Imipramine	Carbamazepine	0.367	1.205	Moderate	7 (4/3)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#F8BABA	0.73108042197962	1
Carbamazepine	Itraconazole	0.206	3.915	Moderate	16 (13/3)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#EFA6A6	1.67104096452484	1
Acenocoumarol	Cholestyramine	0.165	-1.771	None	13 (5/8)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AFCEE4	1.35772078367644	1
Furosemide	Gentamicin	0.129	-1.476	Major	7 (3/4)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#B1CFE5	0.73108042197962	1
Paroxetine	Propafenone	0.309	1.626	Moderate	14 (9/5)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F7B7B7	1.46216084395924	1
Propranolol	Terbutaline	0.146	1.189	Major	44 (25/19)		#F9BCBC	4.59536265244332	1
Cyclosporine	Phenobarbital	0.144	-3.321	Moderate	8 (2/6)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#A3C5DF	0.835520482262422	0.39387028769678
Cyclosporine	Verapamil	0.553	-2.214	Moderate	6 (2/4)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#ABCBE2	0.626640361696817	1
Rifabutin	Tacrolimus	0.08	-1.107	None	2 (1/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifabutin.	#B4D1E6	0.208880120565606	1
Methotrexate	Sulfamethoxazole	0.185	2.484	Moderate	15 (11/4)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#F4B1B1	1.56660090424204	1
Trazodone	Rivastigmine	0.194	-2.767	Moderate	7 (2/5)		#A8C8E1	0.73108042197962	0.0973081692758522
Simvastatin	Fusidic acid	0.115	-1.384	None	54 (24/30)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#B2D0E5	5.63976325527135	1
Phenytoin	Sertraline	0.392	-1.107	Moderate	20 (10/10)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#B4D1E6	2.08880120565606	1
Olanzapine	Galantamine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Cyclosporine	Sevelamer	0.176	-5.535	Moderate	6 (1/5)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#93B8D7	0.626640361696817	0.021868405809282
Metoprolol	Propafenone	0.556	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#B32020	0.104440060282803	1
Halazepam	Ketoconazole	0.062	Inf	None	2 (2/0)		#B32020	0.208880120565606	1
Atenolol	Glipizide	0.326	-1.384	Moderate	9 (4/5)	Atenolol may increase the hypoglycemic activities of Glipizide.	#B2D0E5	0.939960542545225	1
Phenobarbital	Dexamethasone	0.139	2.71	Moderate	8 (6/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#F3AFAF	0.835520482262422	1
Diltiazem	Propranolol	0.383	-1.882	Major	27 (10/17)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#AECDE3	2.81988162763568	1
Losartan	Rifampicin	0.127	-1.107	Moderate	16 (8/8)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#B4D1E6	1.67104096452484	1
Citalopram	Rasagiline	0.277	-1.107	Major	14 (7/7)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#B4D1E6	1.46216084395924	1
Mirtazapine	Rivastigmine	0.247	1.807	Moderate	3 (2/1)		#F6B6B6	0.313320180848408	1
Cyclosporine	Chloroquine	0.25	Inf	Moderate	1 (1/0)	Chloroquine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.104440060282803	1
Fluconazole	Tacrolimus	0.384	-1.906	Major	49 (18/31)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#AECDE3	5.11756295385734	1
Enalapril	Rifampicin	0.162	-3.736	None	70 (16/54)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#A0C3DD	7.3108042197962	1
Atenolol	Piroxicam	0.235	7.227	Moderate	9 (8/1)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#E38B8B	0.939960542545225	1
Eplerenone	Lithium cation	0.298	Inf	Moderate	2 (2/0)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#B32020	0.208880120565606	1
Metoprolol	Ergotamine	0.148	Inf	Moderate	3 (3/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.313320180848408	1
Bupropion	Rasagiline	0.36	-2.767	Major	7 (2/5)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#A8C8E1	0.73108042197962	1
Phenoxymethylpenicillin	Methotrexate	0.079	Inf	Major	8 (8/0)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#B32020	0.835520482262422	1
Tizanidine	Norethisterone	0.178	Inf	Major	20 (20/0)		#B32020	2.08880120565606	1
Citalopram	Metoprolol	0.344	1.242	Moderate	19 (11/8)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F8BABA	1.98436114537325	1
Theophylline	Pentoxifylline	0.282	2.71	Moderate	4 (3/1)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#F3AFAF	0.417760241131211	1
Diclofenac	Warfarin	0.157	-1.739	Major	54 (21/33)	Diclofenac may increase the anticoagulant activities of Warfarin.	#AFCEE4	5.63976325527135	1
Lansoprazole	Itraconazole	0.172	1.971	Moderate	35 (24/11)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F6B6B6	3.6554021098981	1
Simvastatin	Rifampicin	0.132	-3.451	Major	70 (17/53)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#A2C4DE	7.3108042197962	1
Ramipril	Tizanidine	0.121	-1.591	Major	39 (16/23)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#B1CFE5	4.07316235102931	1
Dihydroergotamine	Bisoprolol	0.381	1.205	Moderate	21 (12/9)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F8BABA	2.19324126593886	1
Piroxicam	Alendronic acid	0.132	7.227	None	9 (8/1)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#E38B8B	0.939960542545225	1
Spironolactone	Lisinopril	0.32	-4.032	Major	65 (14/51)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#9DC0DC	6.78860391838218	1
Theophylline	Propafenone	0.8	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#B32020	0.104440060282803	1
Propranolol	Glipizide	0.28	-1.476	Moderate	7 (3/4)	Propranolol may increase the hypoglycemic activities of Glipizide.	#B1CFE5	0.73108042197962	1
Itraconazole	Phenobarbital	0.093	3.162	Moderate	9 (7/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#F2ACAC	0.939960542545225	1
Venlafaxine	Naratriptan	0.042	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#B32020	0.522200301414014	1
Sucralfate	Ciprofloxacin	0.592	1.265	Moderate	36 (21/15)		#F8BABA	3.7598421701809	1
Ciprofloxacin	Tizanidine	0.305	1.453	Major	60 (37/23)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#F7B9B9	6.26640361696817	1
Diltiazem	Tacrolimus	0.32	-1.291	Moderate	13 (6/7)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#B2D0E5	1.35772078367644	1
Isoniazid	Acenocoumarol	0.145	-1.107	None	8 (4/4)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#B4D1E6	0.835520482262422	1
Fluconazole	Cyclophosphamide	0.667	-1.107	None	6 (3/3)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#B4D1E6	0.626640361696817	1
Warfarin	Paroxetine	0.265	1.656	Moderate	17 (11/6)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F7B7B7	1.77548102480765	1
Methylphenidate	Carbamazepine	0.169	-1.992	None	14 (5/9)		#AECDE3	1.46216084395924	1
Doxycycline	Rifampicin	0.635	-1.937	Moderate	11 (4/7)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#AECDE3	1.14884066311083	1
Digoxin	Cholestyramine	0.05	Inf	Moderate	2 (2/0)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.208880120565606	1
Celecoxib	Acenocoumarol	0.099	1.606	None	25 (16/9)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#F7B7B7	2.61100150707007	1
Dextropropoxyphene	Acenocoumarol	0.667	-1.107	None	2 (1/1)		#B4D1E6	0.208880120565606	1
Phenytoin	Fluoxetine	0.366	-1.711	Moderate	28 (11/17)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#AFCEE4	2.92432168791848	1
Ethinylestradiol	Minocycline	0.215	Inf	Moderate	4 (4/0)		#B32020	0.417760241131211	1
Bromocriptine	Methotrimeprazine	0.277	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Methotrimeprazine can be decreased when used in combination with Bromocriptine.	#B32020	0.104440060282803	1
Warfarin	Levofloxacin	0.144	-2.352	Major	25 (8/17)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#ABCBE2	2.61100150707007	1
Cyclosporine	Metoclopramide	0.16	-2.214	Moderate	30 (10/20)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#ABCBE2	3.13320180848408	1
Frovatriptan	Sertraline	0.457	2.409	Major	11 (8/3)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#F4B1B1	1.14884066311083	1
Esomeprazole	Itraconazole	0.35	1.529	Moderate	35 (22/13)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F7B9B9	3.6554021098981	1
Cyclosporine	Norfloxacin	0.155	1.291	Moderate	17 (10/7)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#F8BABA	1.77548102480765	1
Diazepam	Rifampicin	0.219	-1.384	Minor	45 (20/25)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#B2D0E5	4.69980271272613	1
Phenytoin	Trimethoprim	0.115	-3.321	Moderate	16 (4/12)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#A3C5DF	1.67104096452484	1
Carbamazepine	Midazolam	0.119	-1.384	Moderate	9 (4/5)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#B2D0E5	0.939960542545225	1
Trospium	Amitriptyline	0.218	5.42	Moderate	7 (6/1)		#E99999	0.73108042197962	1
Phenytoin	Felodipine	0.067	Inf	Major	1 (1/0)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#B32020	0.104440060282803	1
Cyclosporine	Indomethacin	0.222	-1.771	Moderate	13 (5/8)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#AFCEE4	1.35772078367644	1
Ergotamine	Frovatriptan	0.103	Inf	Major	3 (3/0)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.313320180848408	1
Bumetanide	Ibuprofen	0.295	2.71	Moderate	12 (9/3)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#F3AFAF	1.25328072339363	1
Clonidine	Bisoprolol	0.351	-2.767	Major	7 (2/5)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#A8C8E1	0.73108042197962	1
Betamethasone	Phenobarbital	0.049	Inf	Moderate	3 (3/0)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#B32020	0.313320180848408	1
Tetracycline	Iron	0.36	9.937	Moderate	12 (11/1)		#DA7676	1.25328072339363	1
Azithromycin	Lovastatin	0.14	1.01	Moderate	36 (19/17)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F9BCBC	3.7598421701809	1
Estradiol	Ursodeoxycholic acid	0.235	4.517	None	12 (10/2)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#EDA1A1	1.25328072339363	1
Valsartan	Lithium cation	0.26	-2.546	Moderate	33 (10/23)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#A9C9E1	3.44652198933249	1
Trospium	Oxybutynin	0.5	-1.107	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#B4D1E6	0.208880120565606	1
Clozapine	Alprazolam	0.335	1.355	Major	10 (6/4)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#F8BABA	1.04440060282803	1
Phenytoin	Midazolam	0.101	1.807	Moderate	3 (2/1)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#F6B6B6	0.313320180848408	1
Tobramycin	Furosemide	0.119	-1.107	Major	2 (1/1)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#B4D1E6	0.208880120565606	1
Fluvoxamine	Phenytoin	0.431	-2.214	Moderate	6 (2/4)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#ABCBE2	0.626640361696817	1
Biperiden	Donepezil	0.25	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#B32020	0.104440060282803	1
Spironolactone	Captopril	0.306	-2.878	Major	18 (5/13)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#A6C7E0	1.87992108509045	1
Pravastatin	Colchicine	0.142	-6.199	Major	33 (5/28)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#8EB5D5	3.44652198933249	1
Fluvoxamine	Rizatriptan	0.171	Inf	Major	6 (6/0)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.626640361696817	1
Citalopram	Pimozide	0.49	1.129	Major	9 (5/4)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F9BCBC	0.939960542545225	1
Amitriptyline	Epinephrine	0.214	13.551	Major	16 (15/1)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#CD5A5A	1.67104096452484	1
Indomethacin	Nadolol	0.381	1.581	Moderate	11 (7/4)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#F7B9B9	1.14884066311083	1
Diazepam	Josamycin	0.247	4.969	None	26 (22/4)		#EB9E9E	2.71544156735287	1
Rosuvastatin	Colchicine	0.145	-7.749	Moderate	32 (4/28)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#82ACD0	3.34208192904969	1
Tamoxifen	Rifampicin	0.09	4.517	Moderate	6 (5/1)	The metabolism of Tamoxifen can be increased when combined with Rifampicin.	#EDA1A1	0.626640361696817	1
Fluoxetine	Doxepin	0.196	1.807	Major	6 (4/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#F6B6B6	0.626640361696817	1
Nortriptyline	Salbutamol	0.165	4.969	Moderate	13 (11/2)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#EB9E9E	1.35772078367644	1
Sertraline	Cilostazol	0.366	-1.992	Moderate	14 (5/9)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#AECDE3	1.46216084395924	1
Doxycycline	Methotrexate	0.164	1.129	Moderate	18 (10/8)		#F9BCBC	1.87992108509045	1
Fluvoxamine	Almotriptan	0.173	3.614	Major	5 (4/1)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#F0A7A7	0.522200301414014	1
Digoxin	Hydroxychloroquine	0.171	1.355	Moderate	5 (3/2)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F8BABA	0.522200301414014	1
Fluconazole	Acenocoumarol	0.18	-1.265	None	30 (14/16)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B2D0E5	3.13320180848408	1
Salbutamol	Nadolol	0.257	1.016	Major	34 (18/16)		#F9BCBC	3.5509620496153	1
Rifampicin	Dexamethasone	0.359	-1.107	Moderate	8 (4/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#B4D1E6	0.835520482262422	1
Tenoxicam	Alendronic acid	0.22	Inf	None	4 (4/0)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#B32020	0.417760241131211	1
Azithromycin	Warfarin	0.115	1.355	Moderate	20 (12/8)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#F8BABA	2.08880120565606	1
Rifampicin	Atorvastatin	0.141	-4.289	Major	39 (8/31)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#9CBFDB	4.07316235102931	1
Lovastatin	Clarithromycin	0.086	-1.107	Major	26 (13/13)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#B4D1E6	2.71544156735287	1
Propranolol	Hydralazine	0.533	-1.476	Minor	7 (3/4)	Hydralazine may increase the hypotensive activities of Propranolol.	#B1CFE5	0.73108042197962	1
Warfarin	Minocycline	0.087	Inf	Moderate	2 (2/0)	Minocycline may increase the anticoagulant activities of Warfarin.	#B32020	0.208880120565606	1
Fludrocortisone	Acenocoumarol	0.188	1.807	None	3 (2/1)		#F6B6B6	0.313320180848408	1
Metoprolol	Repaglinide	0.667	1.807	Moderate	3 (2/1)		#F6B6B6	0.313320180848408	1
Spironolactone	Quinapril	0.413	-2.767	Major	7 (2/5)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#A8C8E1	0.73108042197962	1
Doxycycline	Acenocoumarol	0.125	-1.799	None	21 (8/13)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#AFCEE4	2.19324126593886	1
Erythromycin	Midazolam	0.15	Inf	Moderate	5 (5/0)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#B32020	0.522200301414014	1
Clonidine	Clomipramine	0.167	Inf	Major	1 (1/0)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#B32020	0.104440060282803	1
Salmeterol	Nadolol	0.241	1.445	Major	13 (8/5)		#F7B9B9	1.35772078367644	1
Carbamazepine	Clarithromycin	0.131	-1.223	Major	40 (19/21)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#B2D0E5	4.17760241131211	1
Telithromycin	Acenocoumarol	0.059	Inf	None	1 (1/0)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#B32020	0.104440060282803	1
Cyclosporine	Rosuvastatin	0.372	-2.583	Major	10 (3/7)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#A9C9E1	1.04440060282803	1
Clarithromycin	Solifenacin	0.227	1.987	Major	32 (22/10)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F6B6B6	3.34208192904969	1
Cyclosporine	Methylphenidate	0.112	Inf	Minor	2 (2/0)		#B32020	0.208880120565606	1
Propranolol	Verapamil	0.348	1.355	Major	10 (6/4)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F8BABA	1.04440060282803	1
Celecoxib	Lithium cation	0.129	1.987	Major	16 (11/5)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F6B6B6	1.67104096452484	1
Metronidazole	Acenocoumarol	0.127	-1.819	None	37 (14/23)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#AECDE3	3.8642822304637	1
Olanzapine	Rivastigmine	0.051	-2.214	Moderate	3 (1/2)		#ABCBE2	0.313320180848408	1
Betamethasone	Acetylsalicylic acid	0.136	-1.581	Moderate	34 (14/20)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B1CFE5	3.5509620496153	1
Eletriptan	Clarithromycin	0.078	10.841	Major	13 (12/1)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#D66F6F	1.35772078367644	1
Diclofenac	Rifampicin	0.341	-1.66	Moderate	45 (18/27)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#AFCEE4	4.69980271272613	1
Atenolol	Epinephrine	0.195	2.258	Moderate	14 (10/4)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F5B2B2	1.46216084395924	1
Ergotamine	Itraconazole	0.259	4.517	Major	12 (10/2)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#EDA1A1	1.25328072339363	1
Donepezil	Tolterodine	0.281	-2.214	Moderate	3 (1/2)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#ABCBE2	0.313320180848408	1
Lithium cation	Etoricoxib	0.142	3.312	None	14 (11/3)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#F1ABAB	1.46216084395924	1
Ketoconazole	Acenocoumarol	0.52	2.71	None	4 (3/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#F3AFAF	0.417760241131211	1
Isotretinoin	Minocycline	0.067	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Minocycline is combined with Isotretinoin.	#B32020	0.104440060282803	1
Trospium	Tiotropium	0.536	Inf	Moderate	2 (2/0)	Trospium may increase the anticholinergic activities of Tiotropium.	#B32020	0.208880120565606	1
Doxycycline	Phenobarbital	0.099	-1.107	Moderate	8 (4/4)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.835520482262422	1
Methylprednisolone	Itraconazole	0.364	1.506	Major	24 (15/9)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#F7B9B9	2.50656144678727	1
Lidocaine	Carvedilol	0.07	-1.107	Moderate	10 (5/5)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#B4D1E6	1.04440060282803	1
Phenytoin	Acenocoumarol	0.32	-5.535	None	18 (3/15)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#93B8D7	1.87992108509045	1
Dihydroergotamine	Ketoconazole	0.225	Inf	Major	2 (2/0)	The serum concentration of Dihydroergotamine can be increased when it is combined with Ketoconazole.	#B32020	0.208880120565606	1
Labetalol	Repaglinide	0.029	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Fluconazole	Haloperidol	0.397	-2.214	Major	24 (8/16)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#ABCBE2	2.50656144678727	1
Propranolol	Repaglinide	0.3	-2.214	Moderate	24 (8/16)		#ABCBE2	2.50656144678727	1
Lisinopril	Lithium cation	0.24	-1.882	Moderate	27 (10/17)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#AECDE3	2.81988162763568	1
Metoprolol	Salbutamol	0.254	-1.107	Moderate	20 (10/10)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	2.08880120565606	1
Indomethacin	Lithium cation	0.136	1.445	Major	13 (8/5)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#F7B9B9	1.35772078367644	1
Naratriptan	Escitalopram	0.205	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#B32020	0.417760241131211	1
Phenytoin	Levodopa	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#B32020	0.104440060282803	1
Carbamazepine	Verapamil	0.477	-2.583	Major	10 (3/7)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#A9C9E1	1.04440060282803	1
Fludrocortisone	Acetylsalicylic acid	0.299	-1.771	Moderate	13 (5/8)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#AFCEE4	1.35772078367644	1
Citalopram	Josamycin	0.088	2.484	None	15 (11/4)		#F4B1B1	1.56660090424204	1
Erythromycin	Carbamazepine	0.105	2.108	Major	10 (7/3)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F5B4B4	1.04440060282803	1
Lovastatin	Verapamil	0.735	-1.107	Major	4 (2/2)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#B4D1E6	0.417760241131211	1
Alendronic acid	Flurbiprofen	0.277	1.355	Moderate	5 (3/2)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#F8BABA	0.522200301414014	1
Fluconazole	Midazolam	0.267	1.054	Major	13 (7/6)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#F9BCBC	1.35772078367644	1
Phenobarbital	Estriol	0.308	Inf	None	3 (3/0)		#B32020	0.313320180848408	1
Fentanyl	Itraconazole	0.227	1.355	Major	20 (12/8)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F8BABA	2.08880120565606	1
Itraconazole	Aripiprazole	0.108	1.807	Moderate	12 (8/4)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#F6B6B6	1.25328072339363	1
Lansoprazole	Ketoconazole	0.194	1.506	Moderate	8 (5/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#F7B9B9	0.835520482262422	1
Lamotrigine	Ethinylestradiol	0.085	Inf	Moderate	4 (4/0)	The serum concentration of Lamotrigine can be decreased when it is combined with Ethinyl Estradiol.	#B32020	0.417760241131211	1
Fluconazole	Celecoxib	0.406	3.614	Moderate	30 (24/6)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F0A7A7	3.13320180848408	1
Minocycline	Iron	0.214	Inf	Moderate	9 (9/0)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.939960542545225	1
Ibandronate	Iron	0.221	Inf	Moderate	13 (13/0)		#B32020	1.35772078367644	1
Ethinylestradiol	Etoricoxib	0.451	Inf	None	9 (9/0)	Etoricoxib may increase the thrombogenic activities of Ethinyl Estradiol.	#B32020	0.939960542545225	1
Doxycycline	Ethinylestradiol	0.264	4.517	Moderate	6 (5/1)	The metabolism of Ethinyl Estradiol can be decreased when combined with Doxycycline.	#EDA1A1	0.626640361696817	1
Repaglinide	Glipizide	0.189	-5.535	None	6 (1/5)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#93B8D7	0.626640361696817	1
Tetracycline	Ethinylestradiol	0.366	Inf	None	3 (3/0)		#B32020	0.313320180848408	1
Disulfiram	Isoniazid	0.244	-2.767	Moderate	7 (2/5)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#A8C8E1	0.73108042197962	1
Imipramine	Terbutaline	0.115	Inf	Moderate	5 (5/0)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#B32020	0.522200301414014	1
Cyclosporine	Nicardipine	0.5	Inf	Moderate	1 (1/0)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#B32020	0.104440060282803	1
Pantoprazole	Ketoconazole	0.454	-1.476	Moderate	14 (6/8)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#B1CFE5	1.46216084395924	1
Fluphenazine	Levofloxacin	0.17	-1.384	Moderate	9 (4/5)		#B2D0E5	0.939960542545225	1
Ergotamine	Clarithromycin	0.243	3.072	Major	22 (17/5)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F2ACAC	2.29768132622166	1
Topiramate	Ethinylestradiol	0.266	Inf	Moderate	7 (7/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Topiramate.	#B32020	0.73108042197962	1
Ziprasidone	Ketoconazole	0.2	Inf	Major	1 (1/0)	The metabolism of Ziprasidone can be decreased when combined with Ketoconazole.	#B32020	0.104440060282803	1
Chlorpromazine	Levofloxacin	0.284	-1.937	Moderate	11 (4/7)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#AECDE3	1.14884066311083	1
Almotriptan	Itraconazole	0.208	2.71	Moderate	12 (9/3)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#F3AFAF	1.25328072339363	1
Fluconazole	Tolterodine	0.22	8.131	Moderate	10 (9/1)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#E08585	1.04440060282803	1
Propranolol	Epinephrine	0.069	2.108	Major	10 (7/3)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B4B4	1.04440060282803	1
Erythromycin	Cabergoline	0.162	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#B32020	0.417760241131211	1
Ergotamine	Nitroglycerin	0.38	3.162	Moderate	9 (7/2)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#F2ACAC	0.939960542545225	1
Dihydroergotamine	Naratriptan	0.037	Inf	Major	1 (1/0)	Dihydroergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.104440060282803	1
Phenytoin	Sucralfate	0.185	1.807	Moderate	3 (2/1)		#F6B6B6	0.313320180848408	1
Nabumetone	Alendronic acid	0.273	7.227	Moderate	9 (8/1)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#E38B8B	0.939960542545225	1
Lovastatin	Bezafibrate	0.2	Inf	None	1 (1/0)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#B32020	0.104440060282803	1
Alendronic acid	Ketoprofen	0.148	Inf	Moderate	6 (6/0)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#B32020	0.626640361696817	1
Metoprolol	Gliclazide	0.372	-4.059	None	14 (3/11)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#9DC0DC	1.46216084395924	1
Tetracycline	Amoxicillin	0.598	2.108	Moderate	50 (35/15)		#F5B4B4	5.22200301414014	1
Amitriptyline	Clonidine	0.205	1.807	Major	3 (2/1)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#F6B6B6	0.313320180848408	1
Sucralfate	Norfloxacin	0.333	-1.022	Moderate	25 (13/12)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#B4D1E6	2.61100150707007	1
Oxytetracycline	Cloxacillin	1	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Midazolam	Clarithromycin	0.19	2.258	Moderate	14 (10/4)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F5B2B2	1.46216084395924	1
Disopyramide	Omeprazole	0.445	-4.428	None	10 (2/8)		#9ABEDB	1.04440060282803	1
Mirtazapine	Galantamine	0.2	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Theophylline	Rifampicin	0.1	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#B32020	0.104440060282803	1
Perphenazine	Levofloxacin	0.054	2.71	Moderate	8 (6/2)		#F3AFAF	0.835520482262422	1
Cyclosporine	Fluoxetine	0.207	1.054	Moderate	13 (7/6)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F9BCBC	1.35772078367644	1
Fluoxetine	Trimipramine	0.65	-1.107	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B4D1E6	0.208880120565606	1
Minocycline	Cloxacillin	0.602	-1.245	Moderate	17 (8/9)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#B2D0E5	1.77548102480765	1
Repaglinide	Glucosamine	0.23	1.265	None	12 (7/5)		#F8BABA	1.25328072339363	1
Carbamazepine	Warfarin	0.354	-2.767	Moderate	7 (2/5)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#A8C8E1	0.73108042197962	1
Nifedipine	Phenobarbital	0.4	-1.66	Major	5 (2/3)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#AFCEE4	0.522200301414014	1
Phenytoin	Estradiol	0.249	Inf	Moderate	4 (4/0)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.417760241131211	1
Erythromycin	Eplerenone	0.063	-2.214	Moderate	6 (2/4)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#ABCBE2	0.626640361696817	1
Fluconazole	Ergotamine	0.334	Inf	Moderate	10 (10/0)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#B32020	1.04440060282803	1
Levofloxacin	Josamycin	0.768	1.581	None	11 (7/4)		#F7B9B9	1.14884066311083	1
Indomethacin	Carvedilol	0.125	-5.693	Moderate	43 (7/36)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#91B7D7	4.49092259216052	1
Carvedilol	Insulin glulisine	0.253	-9.409	Moderate	19 (2/17)		#76A3CB	1.98436114537325	0.163564984482996
Pravastatin	Bezafibrate	0.452	-3.874	None	9 (2/7)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#9FC1DD	0.939960542545225	1
Dexamethasone	Acenocoumarol	0.184	-2.214	None	21 (7/14)		#ABCBE2	2.19324126593886	1
Warfarin	Gemfibrozil	0.207	-4.428	Major	15 (3/12)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#9ABEDB	1.56660090424204	1
Atenolol	Prazosin	0.457	Inf	Moderate	1 (1/0)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.104440060282803	1
Olmesartan	Drospirenone	0.183	Inf	Moderate	2 (2/0)	Olmesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.208880120565606	1
Bisoprolol	Rifampicin	0.16	-3.764	Moderate	22 (5/17)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#A0C3DD	2.29768132622166	1
Tacrolimus	Metronidazole	0.257	-1.384	Moderate	27 (12/15)		#B2D0E5	2.81988162763568	1
Enalapril	Drospirenone	0.19	6.324	Moderate	8 (7/1)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#E69393	0.835520482262422	1
Fentanyl	Amiodarone	0.372	-2.952	Major	11 (3/8)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#A6C7E0	1.14884066311083	1
Metoprolol	Sertraline	0.337	2.258	Moderate	7 (5/2)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#F5B2B2	0.73108042197962	1
Phenytoin	Itraconazole	0.088	1.807	Moderate	6 (4/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#F6B6B6	0.626640361696817	1
Salbutamol	Doxepin	0.219	3.614	Moderate	5 (4/1)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#F0A7A7	0.522200301414014	1
Triamcinolone	Phenobarbital	0.035	-1.384	Moderate	9 (4/5)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#B2D0E5	0.939960542545225	1
Eletriptan	Itraconazole	0.144	Inf	Major	5 (5/0)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#B32020	0.522200301414014	1
Phenytoin	Warfarin	0.288	-1.107	Moderate	2 (1/1)	Phenytoin may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.208880120565606	1
Telmisartan	Lithium cation	0.276	-1.384	Moderate	9 (4/5)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B2D0E5	0.939960542545225	1
Cyclosporine	Carbamazepine	0.095	-1.66	Major	5 (2/3)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#AFCEE4	0.522200301414014	1
Oxcarbazepine	Felodipine	0.271	-2.214	Moderate	3 (1/2)		#ABCBE2	0.313320180848408	1
Allopurinol	Mercaptopurine	0.374	-2.214	Major	3 (1/2)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#ABCBE2	0.313320180848408	1
Sumatriptan	Lithium cation	0.217	-3.542	None	21 (5/16)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#A2C4DE	2.19324126593886	1
Piroxicam	Propranolol	0.543	Inf	Moderate	4 (4/0)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#B32020	0.417760241131211	1
Phenytoin	Theophylline	0.211	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#B32020	0.104440060282803	1
Itraconazole	Clarithromycin	0.551	2.135	Moderate	37 (26/11)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F5B4B4	3.8642822304637	1
Venlafaxine	Rasagiline	0.318	-2.583	Major	10 (3/7)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#A9C9E1	1.04440060282803	1
Fluconazole	Dihydroergotamine	0.552	3.162	Moderate	9 (7/2)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#F2ACAC	0.939960542545225	1
Triamcinolone	Warfarin	0.133	2.71	Moderate	4 (3/1)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#F3AFAF	0.417760241131211	1
Norethisterone	Phenobarbital	0.53	Inf	Major	5 (5/0)	The metabolism of Norethisterone can be increased when combined with Phenobarbital.	#B32020	0.522200301414014	1
Warfarin	Ranitidine	0.27	-5.313	Moderate	29 (5/24)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#94B9D8	3.02876174820128	1
Cyclosporine	Amiodarone	0.49	-4.428	Moderate	5 (1/4)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#9ABEDB	0.522200301414014	1
Trospium	Biperiden	0.038	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#B32020	0.104440060282803	1
Atomoxetine	Terbinafine	0.083	Inf	Moderate	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Terbinafine.	#B32020	0.104440060282803	1
Cyclosporine	Phenytoin	0.151	-1.107	Moderate	2 (1/1)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B4D1E6	0.208880120565606	1
Colestipol	Levothyroxine	0.264	1.129	Moderate	9 (5/4)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F9BCBC	0.939960542545225	1
Fluconazole	Lovastatin	0.102	2.71	Major	8 (6/2)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F3AFAF	0.835520482262422	1
Ketoconazole	Pioglitazone	0.018	Inf	Moderate	1 (1/0)	The metabolism of Pioglitazone can be decreased when combined with Ketoconazole.	#B32020	0.104440060282803	1
Ramipril	Lithium cation	0.36	-2.952	Moderate	22 (6/16)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#A6C7E0	2.29768132622166	1
Doxycycline	Cloxacillin	0.569	-2.122	Moderate	35 (12/23)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#ACCCE3	3.6554021098981	1
Rifampicin	Gliclazide	0.134	-3.321	None	12 (3/9)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#A3C5DF	1.25328072339363	1
Hydrocortisone	Cholestyramine	0.319	3.614	Moderate	5 (4/1)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F0A7A7	0.522200301414014	1
Diltiazem	Midazolam	0.356	-1.66	Moderate	5 (2/3)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#AFCEE4	0.522200301414014	1
Pseudoephedrine	Moclobemide	0.2	Inf	None	1 (1/0)	Moclobemide may increase the hypertensive activities of Pseudoephedrine.	#B32020	0.104440060282803	1
Clozapine	Ciprofloxacin	0.086	Inf	Major	3 (3/0)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#B32020	0.313320180848408	1
Lovastatin	Acenocoumarol	0.368	-2.952	None	11 (3/8)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#A6C7E0	1.14884066311083	1
Halazepam	Itraconazole	0.339	1.807	None	6 (4/2)		#F6B6B6	0.626640361696817	1
Phenytoin	Rifampicin	0.109	-1.107	Major	2 (1/1)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#B4D1E6	0.208880120565606	1
Glyburide	Glucosamine	0.228	-1.245	None	17 (8/9)		#B2D0E5	1.77548102480765	1
Doxycycline	Iron	0.496	5.42	Moderate	14 (12/2)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#E99999	1.46216084395924	1
Theophylline	Isoniazid	0.341	-1.107	Moderate	2 (1/1)	The serum concentration of Theophylline can be increased when it is combined with Isoniazid.	#B4D1E6	0.208880120565606	1
Tizanidine	Perindopril	0.075	Inf	Major	3 (3/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#B32020	0.313320180848408	1
Cyproheptadine	Fluoxetine	0.556	1.807	Moderate	3 (2/1)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#F6B6B6	0.313320180848408	1
Warfarin	Naproxen	0.12	1.549	Major	19 (12/7)	Naproxen may increase the anticoagulant activities of Warfarin.	#F7B9B9	1.98436114537325	1
Naratriptan	Sertraline	0.153	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#B32020	0.313320180848408	1
Fluvoxamine	Zolmitriptan	0.326	3.614	Moderate	5 (4/1)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#F0A7A7	0.522200301414014	1
Diltiazem	Carbamazepine	0.34	-2.583	Major	10 (3/7)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#A9C9E1	1.04440060282803	1
Methylprednisolone	Rifampicin	0.111	-1.107	Moderate	6 (3/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B4D1E6	0.626640361696817	1
Glyburide	Rifampicin	0.344	-1.66	Moderate	5 (2/3)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#AFCEE4	0.522200301414014	1
Warfarin	Norfloxacin	0.245	-1.291	Major	13 (6/7)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#B2D0E5	1.35772078367644	1
Trospium	Loratadine	0.253	4.517	None	6 (5/1)		#EDA1A1	0.626640361696817	1
Methotrexate	Tetracycline	0.067	Inf	Moderate	4 (4/0)		#B32020	0.417760241131211	1
Chlorthalidone	Lithium cation	0.14	Inf	Major	3 (3/0)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#B32020	0.313320180848408	1
Hydroxyzine	Galantamine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Phenytoin	Norethisterone	0.191	Inf	None	4 (4/0)	The metabolism of Norethisterone can be increased when combined with Phenytoin.	#B32020	0.417760241131211	1
Dihydroergotamine	Clarithromycin	0.317	1.807	Major	15 (10/5)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#F6B6B6	1.56660090424204	1
Griseofulvin	Estradiol	0.667	Inf	Moderate	1 (1/0)	The metabolism of Estradiol can be increased when combined with Griseofulvin.	#B32020	0.104440060282803	1
Prednisone	Estriol	0.412	Inf	None	17 (17/0)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#B32020	1.77548102480765	1
Paroxetine	Moclobemide	0.266	-1.107	None	4 (2/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B4D1E6	0.417760241131211	1
Mefenamic acid	Lithium cation	0.029	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Mefenamic acid.	#B32020	0.104440060282803	1
Ergotamine	Ketoconazole	0.583	Inf	Major	2 (2/0)	The serum concentration of Ergotamine can be increased when it is combined with Ketoconazole.	#B32020	0.208880120565606	1
Tolterodine	Itraconazole	0.271	2.71	Moderate	8 (6/2)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F3AFAF	0.835520482262422	1
Losartan	Drospirenone	0.05	Inf	Moderate	3 (3/0)	Losartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.313320180848408	1
Sotalol	Ergotamine	0.5	Inf	Moderate	1 (1/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.104440060282803	1
Cyclosporine	Naproxen	0.156	-1.568	Moderate	29 (12/17)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	3.02876174820128	1
Omeprazole	Chlordiazepoxide	0.312	-1.107	Moderate	6 (3/3)		#B4D1E6	0.626640361696817	1
Ketoconazole	Budesonide	0.288	1.807	Major	15 (10/5)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#F6B6B6	1.56660090424204	1
Metoprolol	Paroxetine	0.404	-1.476	Moderate	14 (6/8)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#B1CFE5	1.46216084395924	1
Phenytoin	Amiodarone	0.595	-6.642	Moderate	7 (1/6)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#89B1D3	0.73108042197962	1
Fluvoxamine	Nortriptyline	0.568	-1.107	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#B4D1E6	0.208880120565606	1
Imipramine	Rifampicin	0.12	Inf	Minor	1 (1/0)	The metabolism of Imipramine can be increased when combined with Rifampicin.	#B32020	0.104440060282803	1
Duloxetine	Propafenone	0.238	2.71	Moderate	4 (3/1)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F3AFAF	0.417760241131211	1
Conjugated estrogens	Prednisone	0.141	Inf	Moderate	7 (7/0)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#B32020	0.73108042197962	1
Cyclosporine	Diclofenac	0.19	-1.291	Moderate	26 (12/14)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	2.71544156735287	1
Phenytoin	Triamcinolone	0.101	-1.476	Moderate	7 (3/4)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#B1CFE5	0.73108042197962	1
Rifampicin	Acenocoumarol	0.068	-2.767	None	7 (2/5)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#A8C8E1	0.73108042197962	1
Theophylline	Phenobarbital	0.175	-2.214	Moderate	3 (1/2)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#ABCBE2	0.313320180848408	1
Naltrexone	Buprenorphine	0.05	-2.214	Major	3 (1/2)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#ABCBE2	0.313320180848408	1
Atorvastatin	Josamycin	0.145	-1.66	None	15 (6/9)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#AFCEE4	1.56660090424204	1
Dextromethorphan	Terbinafine	0.683	1.807	Major	21 (14/7)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F6B6B6	2.19324126593886	1
Alprazolam	Telithromycin	0.066	2.71	Moderate	4 (3/1)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#F3AFAF	0.417760241131211	1
Methotrexate	Cholestyramine	0.104	-1.107	None	6 (3/3)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.626640361696817	1
Prednisone	Ketoconazole	0.512	1.205	Moderate	14 (8/6)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#F8BABA	1.46216084395924	1
Mirtazapine	Clonidine	0.5	-1.107	Moderate	2 (1/1)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#B4D1E6	0.208880120565606	1
Atenolol	Insulin glulisine	0.251	-3.044	Moderate	15 (4/11)		#A5C6DF	1.56660090424204	1
Fluvoxamine	Oxycodone	0.537	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#B32020	0.208880120565606	1
Repaglinide	Clarithromycin	0.159	-2.214	Moderate	30 (10/20)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#ABCBE2	3.13320180848408	1
Itraconazole	Acenocoumarol	0.124	-1.423	None	16 (7/9)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B1CFE5	1.67104096452484	1
Doxycycline	Insulin aspart	0.091	-2.878	Moderate	18 (5/13)		#A6C7E0	1.87992108509045	1
Ketoconazole	Clonazepam	0.057	1.807	None	6 (4/2)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#F6B6B6	0.626640361696817	1
Repaglinide	Nadolol	0.313	-1.107	Moderate	4 (2/2)		#B4D1E6	0.417760241131211	1
Ethinylestradiol	Itraconazole	0.235	Inf	Moderate	5 (5/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#B32020	0.522200301414014	1
Sucralfate	Levofloxacin	0.613	-1.384	Moderate	18 (8/10)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B2D0E5	1.87992108509045	1
Fluvoxamine	Warfarin	0.192	-2.214	Moderate	3 (1/2)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#ABCBE2	0.313320180848408	1
Cimetidine	Diazepam	0.373	3.614	Moderate	5 (4/1)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#F0A7A7	0.522200301414014	1
Phenytoin	Clarithromycin	0.191	-1.476	Moderate	14 (6/8)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B1CFE5	1.46216084395924	1
Trazodone	Warfarin	0.18	-3.69	Minor	13 (3/10)	Trazodone may decrease the anticoagulant activities of Warfarin.	#A0C3DD	1.35772078367644	1
Phenytoin	Medroxyprogesterone acetate	0.232	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Phenytoin.	#B32020	0.208880120565606	1
Galantamine	Sertraline	0.618	-1.107	Moderate	2 (1/1)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#B4D1E6	0.208880120565606	1
Propranolol	Rifampicin	0.216	-1.476	Moderate	7 (3/4)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#B1CFE5	0.73108042197962	1
Fluconazole	Halazepam	0.111	1.807	None	6 (4/2)		#F6B6B6	0.626640361696817	1
Metformin	Cimetidine	0.238	Inf	Moderate	2 (2/0)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#B32020	0.208880120565606	1
Tacrolimus	Ketoconazole	0.75	Inf	Major	2 (2/0)	The serum concentration of Tacrolimus can be increased when it is combined with Ketoconazole.	#B32020	0.208880120565606	1
Lovastatin	Warfarin	0.38	-3.321	Moderate	4 (1/3)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#A3C5DF	0.417760241131211	1
Moxifloxacin	Josamycin	0.778	Inf	None	3 (3/0)		#B32020	0.313320180848408	1
Tacrolimus	Itraconazole	0.527	-1.898	Major	19 (7/12)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#AECDE3	1.98436114537325	1
Doxycycline	Ampicillin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#B32020	0.104440060282803	1
Ethinylestradiol	Cloxacillin	0.473	Inf	Moderate	6 (6/0)		#B32020	0.626640361696817	1
Phenytoin	Tacrolimus	0.188	-2.214	Major	6 (2/4)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#ABCBE2	0.626640361696817	1
Capecitabine	Acenocoumarol	0.571	-1.107	None	2 (1/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#B4D1E6	0.208880120565606	1
Theophylline	Norfloxacin	0.089	2.258	Moderate	7 (5/2)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#F5B2B2	0.73108042197962	1
Tizanidine	Captopril	0.117	3.614	Major	5 (4/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#F0A7A7	0.522200301414014	1
Erythromycin	Lovastatin	0.244	-1.107	Major	6 (3/3)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#B4D1E6	0.626640361696817	1
Warfarin	Fenofibrate	0.293	-12.176	Major	24 (2/22)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#6093C2	2.50656144678727	1
Tizanidine	Donepezil	0.875	Inf	Moderate	1 (1/0)	Tizanidine may increase the bradycardic activities of Donepezil.	#B32020	0.104440060282803	1
Spironolactone	Eprosartan	0.293	-1.66	Major	5 (2/3)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#AFCEE4	0.522200301414014	1
Cyclosporine	Lovastatin	0.056	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#B32020	0.104440060282803	1
Erythromycin	Warfarin	0.04	-1.107	Major	4 (2/2)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#B4D1E6	0.417760241131211	1
Atenolol	Clonidine	0.458	-1.107	Major	2 (1/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B4D1E6	0.208880120565606	1
Haloperidol	Itraconazole	0.309	1.807	Moderate	6 (4/2)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#F6B6B6	0.626640361696817	1
Fluvoxamine	Tizanidine	0.256	2.71	Major	4 (3/1)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#F3AFAF	0.417760241131211	1
Codeine	Cimetidine	0.144	2.71	Moderate	4 (3/1)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#F3AFAF	0.417760241131211	1
Duloxetine	Rasagiline	0.246	-1.107	Major	4 (2/2)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#B4D1E6	0.417760241131211	1
Ofloxacin	Iron	0.417	Inf	None	3 (3/0)		#B32020	0.313320180848408	1
Salbutamol	Moclobemide	0.082	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#B32020	0.208880120565606	1
Colestipol	Raloxifene	0.038	Inf	Moderate	1 (1/0)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.104440060282803	1
Doxycycline	Carbamazepine	0.229	-2.214	Moderate	12 (4/8)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#ABCBE2	1.25328072339363	1
Medroxyprogesterone acetate	Acenocoumarol	0.175	Inf	None	4 (4/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.417760241131211	1
Trospium	Ipratropium	0.12	2.71	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#F3AFAF	0.417760241131211	1
Torasemide	Gentamicin	0.103	-1.107	Major	2 (1/1)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#B4D1E6	0.208880120565606	1
Metoprolol	Dihydroergotamine	0.111	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.104440060282803	1
Erythromycin	Zafirlukast	0.231	Inf	Moderate	1 (1/0)	The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.	#B32020	0.104440060282803	1
Clozapine	Fluoxetine	0.161	-2.767	Moderate	7 (2/5)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#A8C8E1	0.73108042197962	1
Meloxicam	Lithium cation	0.417	Inf	Major	4 (4/0)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#B32020	0.417760241131211	1
Norethisterone	Primidone	0.75	-1.107	None	2 (1/1)	The metabolism of Norethisterone can be increased when combined with Primidone.	#B4D1E6	0.208880120565606	1
Pregabalin	Rosiglitazone	0.407	-2.214	Moderate	9 (3/6)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#ABCBE2	0.939960542545225	1
Desogestrel	Lamotrigine	0.153	Inf	Moderate	3 (3/0)	Desogestrel may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.	#B32020	0.313320180848408	1
Warfarin	Dexamethasone	0.395	-1.107	Moderate	4 (2/2)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.417760241131211	1
Fentanyl	Rifampicin	0.185	-3.321	Major	8 (2/6)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#A3C5DF	0.835520482262422	1
Tenoxicam	Acenocoumarol	0.091	Inf	None	1 (1/0)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.104440060282803	1
Imipramine	Pseudoephedrine	0.043	Inf	None	3 (3/0)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.313320180848408	1
Paroxetine	Rasagiline	0.258	-2.214	Major	9 (3/6)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#ABCBE2	0.939960542545225	1
Nabumetone	Warfarin	0.212	Inf	Major	1 (1/0)	Nabumetone may increase the anticoagulant activities of Warfarin.	#B32020	0.104440060282803	1
Phenytoin	Flurazepam	1	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#B32020	0.104440060282803	1
Trazodone	Ketoconazole	0.134	-1.107	Moderate	6 (3/3)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B4D1E6	0.626640361696817	1
Rifampicin	Clarithromycin	0.672	-1.328	Moderate	11 (5/6)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#B2D0E5	1.14884066311083	1
Formoterol	Nadolol	0.221	-1.291	Major	13 (6/7)		#B2D0E5	1.35772078367644	1
Erythromycin	Tacrolimus	0.298	2.258	Major	7 (5/2)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#F5B2B2	0.73108042197962	1
Lovastatin	Carbamazepine	0.296	-1.107	None	4 (2/2)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#B4D1E6	0.417760241131211	1
Fluvoxamine	Ergotamine	0.172	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#B32020	0.208880120565606	1
Theophylline	Terbinafine	0.333	1.807	Moderate	3 (2/1)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#F6B6B6	0.313320180848408	1
Sucralfate	Ofloxacin	0.111	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Rifabutin	Atorvastatin	0.131	-2.214	Moderate	3 (1/2)	The metabolism of Atorvastatin can be increased when combined with Rifabutin.	#ABCBE2	0.313320180848408	1
Warfarin	Disulfiram	0.078	-1.107	Moderate	2 (1/1)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#B4D1E6	0.208880120565606	1
Trospium	Desloratadine	0.068	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#B32020	0.208880120565606	1
Erythromycin	Lincomycin	0.812	-3.321	Moderate	4 (1/3)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#A3C5DF	0.417760241131211	1
Trospium	Risperidone	0.038	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Medroxyprogesterone acetate	Phenobarbital	0.235	Inf	Moderate	2 (2/0)	The metabolism of Medroxyprogesterone acetate can be increased when combined with Phenobarbital.	#B32020	0.208880120565606	1
Disulfiram	Metronidazole	0.345	-2.214	Major	15 (5/10)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#ABCBE2	1.56660090424204	1
Phenytoin	Methotrexate	0.334	-1.66	Moderate	5 (2/3)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#AFCEE4	0.522200301414014	1
Telmisartan	Drospirenone	0.043	Inf	Moderate	1 (1/0)	Telmisartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.104440060282803	1
Fluconazole	Fluvastatin	0.072	1.129	Moderate	9 (5/4)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	0.939960542545225	1
Codeine	Naltrexone	0.221	-2.435	Major	16 (5/11)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#A9C9E1	1.67104096452484	1
Verapamil	Colchicine	0.088	-6.642	Major	7 (1/6)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#89B1D3	0.73108042197962	1
Labetalol	Salbutamol	0.157	Inf	Major	3 (3/0)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#B32020	0.313320180848408	1
Triamcinolone	Acenocoumarol	0.09	-1.771	None	13 (5/8)		#AFCEE4	1.35772078367644	1
Dihydroergotamine	Carvedilol	0.06	-1.66	Moderate	5 (2/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#AFCEE4	0.522200301414014	1
Irbesartan	Drospirenone	0.077	Inf	Moderate	1 (1/0)	Irbesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.104440060282803	1
Piroxicam	Nadolol	0.333	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Nadolol.	#B32020	0.104440060282803	1
Verapamil	Phenobarbital	0.351	-1.107	Moderate	2 (1/1)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#B4D1E6	0.208880120565606	1
Fluconazole	Rifampicin	0.516	-1.476	Major	7 (3/4)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#B1CFE5	0.73108042197962	1
Glimepiride	Glucosamine	0.202	-1.384	None	9 (4/5)		#B2D0E5	0.939960542545225	1
Erythromycin	Sotalol	0.189	-1.107	Major	2 (1/1)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.208880120565606	1
Erythromycin	Itraconazole	0.577	1.054	Major	13 (7/6)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#F9BCBC	1.35772078367644	1
Ropinirole	Ciprofloxacin	0.091	1.205	Moderate	7 (4/3)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#F8BABA	0.73108042197962	1
Ibuprofen	Oxprenolol	0.093	1.807	None	3 (2/1)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F6B6B6	0.313320180848408	1
Gliclazide	Glucosamine	0.233	-2.076	None	23 (8/15)		#ACCCE3	2.40212138650446	1
Fluvoxamine	Acenocoumarol	0.267	-3.321	None	8 (2/6)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#A3C5DF	0.835520482262422	1
Warfarin	Fluvastatin	0.295	-3.321	Minor	4 (1/3)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#A3C5DF	0.417760241131211	1
Erythromycin	Ergotamine	0.244	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#B32020	0.417760241131211	1
Moxifloxacin	Warfarin	0.089	-2.767	Major	7 (2/5)		#A8C8E1	0.73108042197962	1
Metoprolol	Indomethacin	0.126	-1.107	Moderate	4 (2/2)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#B4D1E6	0.417760241131211	1
Tramadol	Moclobemide	0.227	Inf	None	2 (2/0)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#B32020	0.208880120565606	1
Rifampicin	Nifedipine	0.102	-1.107	Major	2 (1/1)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#B4D1E6	0.208880120565606	1
Diazepam	Ketoconazole	0.342	1.162	Moderate	16 (9/7)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F9BCBC	1.67104096452484	1
Primidone	Metronidazole	0.067	Inf	Moderate	1 (1/0)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#B32020	0.104440060282803	1
Sucralfate	Itraconazole	0.377	Inf	None	4 (4/0)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.417760241131211	1
Diltiazem	Rifampicin	0.373	-2.214	Major	3 (1/2)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#ABCBE2	0.313320180848408	1
Tacrolimus	Felodipine	0.09	-1.107	Moderate	2 (1/1)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#B4D1E6	0.208880120565606	1
Ethinylestradiol	Ursodeoxycholic acid	0.085	Inf	None	2 (2/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.208880120565606	1
Cyclosporine	Ethinylestradiol	0.182	Inf	Moderate	1 (1/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Cyclosporine.	#B32020	0.104440060282803	1
Sertraline	Moclobemide	0.2	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Sertraline is combined with Moclobemide.	#B32020	0.104440060282803	1
Tetracycline	Insulin glulisine	0.333	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Lovastatin	Josamycin	0.034	Inf	None	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#B32020	0.104440060282803	1
Amitriptyline	Rifampicin	0.344	-1.66	Minor	10 (4/6)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#AFCEE4	1.04440060282803	1
Flurazepam	Itraconazole	0.347	-1.845	None	8 (3/5)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#AECDE3	0.835520482262422	1
Verapamil	Midazolam	0.279	-1.107	Moderate	2 (1/1)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#B4D1E6	0.208880120565606	1
Captopril	Lithium cation	0.283	-1.66	Moderate	5 (2/3)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#AFCEE4	0.522200301414014	1
Midazolam	Itraconazole	0.127	-1.107	Major	6 (3/3)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#B4D1E6	0.626640361696817	1
Rifampicin	Fluvastatin	0.089	-2.214	Moderate	3 (1/2)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#ABCBE2	0.313320180848408	1
Sotalol	Gliclazide	0.088	-3.321	None	4 (1/3)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#A3C5DF	0.417760241131211	1
Hydrocortisone	Rifampicin	0.778	1.807	Moderate	3 (2/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#F6B6B6	0.313320180848408	1
Warfarin	Clarithromycin	0.049	1.807	Major	6 (4/2)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#F6B6B6	0.626640361696817	1
Erythromycin	Repaglinide	0.236	-1.845	Moderate	8 (3/5)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#AECDE3	0.835520482262422	1
Clozapine	Bromazepam	0.571	-1.107	None	2 (1/1)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#B4D1E6	0.208880120565606	1
Raloxifene	Cholestyramine	0.1	Inf	Moderate	2 (2/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.208880120565606	1
Digoxin	Minocycline	0.056	-1.107	Moderate	2 (1/1)		#B4D1E6	0.208880120565606	1
Cyclosporine	Repaglinide	0.669	-4.428	Major	5 (1/4)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#9ABEDB	0.522200301414014	1
Tizanidine	Ethinylestradiol	0.048	Inf	Major	3 (3/0)		#B32020	0.313320180848408	1
Lovastatin	Colchicine	0.267	-1.107	Major	2 (1/1)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#B4D1E6	0.208880120565606	1
Risperidone	Itraconazole	0.2	-2.435	None	16 (5/11)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#A9C9E1	1.67104096452484	1
Indomethacin	Labetalol	0.143	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#B32020	0.104440060282803	1
Trospium	Clomipramine	0.1	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Meloxicam	Acenocoumarol	0.215	-1.107	None	8 (4/4)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.835520482262422	1
Lovastatin	Itraconazole	0.106	-1.476	Major	7 (3/4)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#B1CFE5	0.73108042197962	1
Colestipol	Hydrocortisone	0.534	-3.321	Moderate	4 (1/3)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A3C5DF	0.417760241131211	1
Lovastatin	Tacrolimus	0.261	-2.214	Moderate	6 (2/4)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#ABCBE2	0.626640361696817	1
Piroxicam	Bisoprolol	0.154	1.355	Moderate	5 (3/2)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#F8BABA	0.522200301414014	1
Repaglinide	Rifampicin	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#B32020	0.104440060282803	1
Ethinylestradiol	Ketoconazole	0.2	Inf	Moderate	1 (1/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Ketoconazole.	#B32020	0.104440060282803	1
Ketoconazole	Rabeprazole	0.076	-1.107	Moderate	4 (2/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#B4D1E6	0.417760241131211	1
Fluconazole	Everolimus	0.024	-1.107	Major	2 (1/1)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#B4D1E6	0.208880120565606	1
Erythromycin	Colchicine	0.6	Inf	Major	2 (2/0)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#B32020	0.208880120565606	1
Metoprolol	Formoterol	0.101	1.355	Moderate	5 (3/2)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#F8BABA	0.522200301414014	1
Moxifloxacin	Sotalol	0.185	-1.107	Major	2 (1/1)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.208880120565606	1
Erythromycin	Verapamil	0.055	Inf	Major	2 (2/0)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#B32020	0.208880120565606	1
Clozapine	Lisinopril	0.226	-3.321	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#A3C5DF	0.417760241131211	1
Disulfiram	Acenocoumarol	0.271	-6.642	None	14 (2/12)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#89B1D3	1.46216084395924	1
Fluvoxamine	Sumatriptan	0.129	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B32020	0.208880120565606	1
Prednisolone	Itraconazole	1	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be increased when it is combined with Itraconazole.	#B32020	0.104440060282803	1
Moxifloxacin	Iron	0.313	4.065	Moderate	11 (9/2)		#EEA4A4	1.14884066311083	1
Theophylline	Propranolol	0.114	1.807	Major	3 (2/1)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#F6B6B6	0.313320180848408	1
Erythromycin	Methylergometrine	0.75	-1.107	None	2 (1/1)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Erythromycin.	#B4D1E6	0.208880120565606	1
Tetracycline	Insulin aspart	0.141	-2.214	Moderate	6 (2/4)		#ABCBE2	0.626640361696817	1
Sotalol	Clarithromycin	0.054	-1.107	Major	4 (2/2)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.417760241131211	1
Minocycline	Acenocoumarol	0.113	-1.66	None	5 (2/3)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	0.522200301414014	1
Naltrexone	Fentanyl	0.058	-1.107	Major	2 (1/1)	The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.	#B4D1E6	0.208880120565606	1
Fluoxetine	Rasagiline	0.266	-1.66	Major	5 (2/3)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#AFCEE4	0.522200301414014	1
Erythromycin	Cilostazol	0.041	-1.107	Major	2 (1/1)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#B4D1E6	0.208880120565606	1
Amitriptyline	Moclobemide	0.6	-2.214	None	3 (1/2)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#ABCBE2	0.313320180848408	1
Amiodarone	Clarithromycin	0.42	-1.384	Major	9 (4/5)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#B2D0E5	0.939960542545225	1
Erythromycin	Quetiapine	0.265	-1.328	Major	11 (5/6)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#B2D0E5	1.14884066311083	1
Metoprolol	Salmeterol	0.433	-1.107	Moderate	4 (2/2)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#B4D1E6	0.417760241131211	1
Ketoconazole	Tolterodine	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#B32020	0.104440060282803	1
Imipramine	Epinephrine	0.125	Inf	Major	1 (1/0)	Imipramine may decrease the antihypertensive activities of Epinephrine.	#B32020	0.104440060282803	1
Ranitidine	Ketoconazole	0.508	1.355	Moderate	5 (3/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#F8BABA	0.522200301414014	1
Moxifloxacin	Sucralfate	0.583	1.355	Moderate	5 (3/2)		#F8BABA	0.522200301414014	1
Fluconazole	Nortriptyline	0.129	Inf	Moderate	2 (2/0)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B32020	0.208880120565606	1
Allopurinol	Azathioprine	0.186	-8.302	Major	17 (2/15)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#7DA8CE	1.77548102480765	1
Ketoconazole	Aripiprazole	0.074	-1.107	Moderate	2 (1/1)	The serum concentration of Aripiprazole can be increased when it is combined with Ketoconazole.	#B4D1E6	0.208880120565606	1
Tacrolimus	Clarithromycin	0.193	-1.107	Major	18 (9/9)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#B4D1E6	1.87992108509045	1
Pseudoephedrine	Rasagiline	0.083	Inf	Moderate	1 (1/0)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#B32020	0.104440060282803	1
Telithromycin	Atorvastatin	0.104	-1.107	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#B4D1E6	0.208880120565606	1
Fluconazole	Triazolam	0.429	Inf	Major	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#B32020	0.104440060282803	1
Pyridostigmine	Dexamethasone	0.205	-1.107	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#B4D1E6	0.208880120565606	1
Labetalol	Salmeterol	0.095	Inf	Major	1 (1/0)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#B32020	0.104440060282803	1
Terbutaline	Rasagiline	0.041	-1.107	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#B4D1E6	0.208880120565606	1
Ketoconazole	Atorvastatin	0.159	-4.428	Major	15 (3/12)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#9ABEDB	1.56660090424204	1
Thiethylperazine	Levofloxacin	0.626	2.71	None	12 (9/3)		#F3AFAF	1.25328072339363	1
Fluvoxamine	Dihydroergotamine	0.207	-1.107	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#B4D1E6	0.208880120565606	1
Fluvastatin	Cholestyramine	0.184	-4.428	Moderate	5 (1/4)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#9ABEDB	0.522200301414014	1
Eletriptan	Dihydroergotamine	0.03	Inf	Major	1 (1/0)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#B32020	0.104440060282803	1
Cyclosporine	Clindamycin	0.067	-2.214	Moderate	6 (2/4)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#ABCBE2	0.626640361696817	1
Hydroxyzine	Donepezil	0.1	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Clarithromycin	Colchicine	0.338	-1.66	Major	10 (4/6)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#AFCEE4	1.04440060282803	1
Ciprofloxacin	Rasagiline	0.042	-1.66	Major	5 (2/3)		#AFCEE4	0.522200301414014	1
Indapamide	Lithium cation	0.245	-1.107	Major	4 (2/2)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B4D1E6	0.417760241131211	1
Itraconazole	Josamycin	0.25	Inf	None	2 (2/0)		#B32020	0.208880120565606	1
Warfarin	Cloxacillin	0.049	-3.874	Moderate	9 (2/7)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#9FC1DD	0.939960542545225	1
Pyridostigmine	Triamcinolone	0.138	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.	#B32020	0.104440060282803	1
Dihydroergotamine	Nadolol	0.292	-1.107	Moderate	2 (1/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B4D1E6	0.208880120565606	1
Itraconazole	Solifenacin	0.264	1.807	Major	6 (4/2)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#F6B6B6	0.626640361696817	1
Phenytoin	Estriol	0.2	Inf	None	1 (1/0)		#B32020	0.104440060282803	1
Fluoxetine	Cilostazol	0.221	-4.428	Moderate	10 (2/8)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#9ABEDB	1.04440060282803	1
Amitriptyline	Ketoconazole	0.071	1.355	Moderate	5 (3/2)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#F8BABA	0.522200301414014	1
Pyridostigmine	Hydrocortisone	0.102	-1.107	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B4D1E6	0.208880120565606	1
Trospium	Cyclobenzaprine	0.19	Inf	Moderate	2 (2/0)		#B32020	0.208880120565606	1
Verapamil	Lithium cation	0.358	-21.032	Moderate	20 (1/19)	Verapamil may increase the neurotoxic activities of Lithium.	#1E61A5	2.08880120565606	0.00131622859789937
Citalopram	Moclobemide	0.286	Inf	None	1 (1/0)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#B32020	0.104440060282803	1
Almotriptan	Ketoconazole	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Almotriptan can be increased when it is combined with Ketoconazole.	#B32020	0.104440060282803	1
Celecoxib	Rifampicin	0.414	1.807	Moderate	3 (2/1)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#F6B6B6	0.313320180848408	1
Conjugated estrogens	Raloxifene	0.176	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Gentamicin	Cefuroxime	0.131	-2.214	Moderate	3 (1/2)		#ABCBE2	0.313320180848408	1
Atenolol	Ampicillin	0.091	-1.107	Moderate	2 (1/1)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#B4D1E6	0.208880120565606	1
Digoxin	Indapamide	0.407	-4.428	Moderate	5 (1/4)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#9ABEDB	0.522200301414014	1
Carbamazepine	Josamycin	0.083	Inf	None	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B32020	0.104440060282803	1
Cilostazol	Itraconazole	0.152	-3.321	Major	4 (1/3)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#A3C5DF	0.417760241131211	1
Doxycycline	Warfarin	0.302	-2.214	Moderate	3 (1/2)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#ABCBE2	0.313320180848408	1
Ketoconazole	Solifenacin	0.038	Inf	Major	1 (1/0)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#B32020	0.104440060282803	1
Salbutamol	Rasagiline	0.07	-2.767	Moderate	7 (2/5)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#A8C8E1	0.73108042197962	1
Amitriptyline	Phenylephrine	0.073	-1.107	Major	2 (1/1)	Amitriptyline may increase the vasopressor activities of Phenylephrine.	#B4D1E6	0.208880120565606	1
Rifampicin	Clomipramine	0.095	-2.214	Minor	3 (1/2)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#ABCBE2	0.313320180848408	1
Erythromycin	Theophylline	0.488	-3.321	Moderate	4 (1/3)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#A3C5DF	0.417760241131211	1
Acenocoumarol	Etoricoxib	0.108	-3.598	None	17 (4/13)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#A2C4DE	1.77548102480765	1
Clarithromycin	Everolimus	0.091	Inf	Major	1 (1/0)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#B32020	0.104440060282803	1
Doxycycline	Digoxin	0.244	-4.428	Moderate	5 (1/4)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#9ABEDB	0.522200301414014	1
Terbutaline	Nadolol	0.175	-1.107	Major	4 (2/2)		#B4D1E6	0.417760241131211	1
Warfarin	Meloxicam	0.033	Inf	Major	1 (1/0)	Meloxicam may increase the anticoagulant activities of Warfarin.	#B32020	0.104440060282803	1
Cyclosporine	Erythromycin	0.028	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#B32020	0.104440060282803	1
Acitretin	Norethisterone	0.05	Inf	None	1 (1/0)		#B32020	0.104440060282803	1
Labetalol	Formoterol	0.059	Inf	Major	1 (1/0)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B32020	0.104440060282803	1
Moxifloxacin	Ziprasidone	0.029	Inf	Major	1 (1/0)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.104440060282803	1
Famotidine	Itraconazole	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#B32020	0.104440060282803	1
Piroxicam	Methotrexate	0.319	-2.214	Major	3 (1/2)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#ABCBE2	0.313320180848408	1
Sirolimus	Clarithromycin	0.071	Inf	Major	1 (1/0)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#B32020	0.104440060282803	1
Tramadol	Rasagiline	0.127	-3.321	Major	8 (2/6)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#A3C5DF	0.835520482262422	1
Alendronic acid	Mefenamic acid	0.5	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.	#B32020	0.104440060282803	1
Fluconazole	Flurazepam	0.156	-1.66	None	5 (2/3)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#AFCEE4	0.522200301414014	1
Erythromycin	Digoxin	0.154	-3.321	Moderate	4 (1/3)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#A3C5DF	0.417760241131211	1
Lidocaine	Nadolol	0.049	-2.214	Moderate	3 (1/2)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#ABCBE2	0.313320180848408	1
Lisinopril	Drospirenone	0.022	Inf	Moderate	1 (1/0)	Lisinopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.104440060282803	1
Warfarin	Hydrocortisone	0.132	-5.535	Moderate	6 (1/5)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#93B8D7	0.626640361696817	1
Trospium	Hydroxyzine	0.333	Inf	Moderate	1 (1/0)		#B32020	0.104440060282803	1
Prednisolone	Acetylsalicylic acid	0.34	-2.214	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#ABCBE2	0.313320180848408	1
Glyburide	Nadolol	0.275	-7.749	Moderate	8 (1/7)	Nadolol may increase the hypoglycemic activities of Glyburide.	#82ACD0	0.835520482262422	1
Levonorgestrel	Carbamazepine	0.667	Inf	Major	1 (1/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Carbamazepine.	#B32020	0.104440060282803	1
Epinephrine	Carvedilol	0.062	-4.428	Major	5 (1/4)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#9ABEDB	0.522200301414014	1
Citalopram	Clozapine	0.304	-5.535	Major	6 (1/5)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#93B8D7	0.626640361696817	1
Triamcinolone	Rifampicin	0.167	-1.107	Moderate	2 (1/1)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#B4D1E6	0.208880120565606	1
Nortriptyline	Terbutaline	0.028	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#B32020	0.104440060282803	1
Indomethacin	Warfarin	0.171	-6.642	Major	7 (1/6)	Indomethacin may increase the anticoagulant activities of Warfarin.	#89B1D3	0.73108042197962	1
Carbamazepine	Ethinylestradiol	0.667	Inf	Major	1 (1/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Carbamazepine.	#B32020	0.104440060282803	1
Cyclosporine	Clarithromycin	0.107	-3.321	Major	8 (2/6)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#A3C5DF	0.835520482262422	1
Methylprednisolone	Ketoconazole	0.218	-2.214	Major	3 (1/2)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#ABCBE2	0.313320180848408	1
Ketoconazole	Quetiapine	0.019	Inf	Major	1 (1/0)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#B32020	0.104440060282803	1
Imipramine	Terbinafine	0.056	Inf	Moderate	1 (1/0)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#B32020	0.104440060282803	1
Warfarin	Itraconazole	0.059	-3.321	Moderate	4 (1/3)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#A3C5DF	0.417760241131211	1
Amitriptyline	Rasagiline	0.28	-7.749	Major	8 (1/7)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#82ACD0	0.835520482262422	1
Moxifloxacin	Amiodarone	0.091	-5.535	Major	6 (1/5)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#93B8D7	0.626640361696817	1
Cyclosporine	Itraconazole	0.275	-2.214	Major	3 (1/2)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#ABCBE2	0.313320180848408	1
Simvastatin	Telithromycin	0.064	-2.214	Major	3 (1/2)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#ABCBE2	0.313320180848408	1
Rifampicin	Itraconazole	0.583	-1.107	Major	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#B4D1E6	0.208880120565606	1
Tetracycline	Cloxacillin	0.6	Inf	Moderate	2 (2/0)		#B32020	0.208880120565606	1
Venlafaxine	Propafenone	0.099	-1.107	Moderate	2 (1/1)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#B4D1E6	0.208880120565606	1
Cyclobenzaprine	Rasagiline	0.037	-3.321	Major	4 (1/3)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#A3C5DF	0.417760241131211	1
Pioglitazone	Glucosamine	0.306	-3.321	None	4 (1/3)		#A3C5DF	0.417760241131211	1
Alprazolam	Cimetidine	0.387	-3.321	Moderate	4 (1/3)		#A3C5DF	0.417760241131211	1
Ergotamine	Carvedilol	0.447	-3.321	Moderate	4 (1/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#A3C5DF	0.417760241131211	1
Fluconazole	Warfarin	0.268	-1.107	Major	2 (1/1)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#B4D1E6	0.208880120565606	1
Esomeprazole	Ketoconazole	0.147	-3.321	Moderate	4 (1/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#A3C5DF	0.417760241131211	1
Celecoxib	Warfarin	0.033	Inf	Moderate	1 (1/0)	Celecoxib may increase the anticoagulant activities of Warfarin.	#B32020	0.104440060282803	1
Warfarin	Metronidazole	0.171	-4.428	Major	5 (1/4)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#9ABEDB	0.522200301414014	1
Gliclazide	Nadolol	0.154	-4.428	None	5 (1/4)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#9ABEDB	0.522200301414014	1
Erythromycin	Dihydroergotamine	0.2	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#B32020	0.104440060282803	1
Rifampicin	Etoricoxib	1	-2.214	None	3 (1/2)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#ABCBE2	0.313320180848408	1
Eplerenone	Clarithromycin	0.115	-9.962	Major	10 (1/9)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#719FC9	1.04440060282803	1
Fluconazole	Phenytoin	0.117	-5.535	Moderate	6 (1/5)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#93B8D7	0.626640361696817	1
Metoclopramide	Levodopa	0.172	-3.321	Moderate	4 (1/3)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#A3C5DF	0.417760241131211	1
Trospium	Cetirizine	0.062	-1.107	None	2 (1/1)		#B4D1E6	0.208880120565606	1
Terbinafine	Acenocoumarol	0.081	-14.39	None	14 (1/13)		#5086BA	1.46216084395924	1
Digoxin	Clarithromycin	0.144	-5.535	Major	6 (1/5)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#93B8D7	0.626640361696817	1
Phenytoin	Aprepitant	0.25	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Aprepitant.	#1E61A5	0.104440060282803	1
Rivastigmine	Periciazine	0.091	-Inf	None	1 (0/1)		#1E61A5	0.104440060282803	1
Trospium	Clemastine	0.125	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Cyclosporine	Sirolimus	0.107	-Inf	Moderate	4 (0/4)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#1E61A5	0.417760241131211	0.109345012160934
Clozapine	Midazolam	0.44	-Inf	Major	3 (0/3)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#1E61A5	0.313320180848408	1
Methadone	Primidone	0.024	-Inf	Major	1 (0/1)	The serum concentration of Methadone can be decreased when it is combined with Primidone.	#1E61A5	0.104440060282803	1
Fluvoxamine	Doxepin	0.09	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#1E61A5	0.208880120565606	1
Phenytoin	Sulfadiazine	0.056	-Inf	Moderate	1 (0/1)	The metabolism of Sulfadiazine can be increased when combined with Phenytoin.	#1E61A5	0.104440060282803	1
Primidone	Acenocoumarol	0.203	-Inf	None	5 (0/5)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#1E61A5	0.522200301414014	1
Cyclosporine	Rifabutin	0.154	-Inf	None	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Rifabutin.	#1E61A5	0.104440060282803	1
Ziprasidone	Donepezil	0.636	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#1E61A5	0.104440060282803	1
Fluvoxamine	Clozapine	0.049	-Inf	Moderate	2 (0/2)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#1E61A5	0.208880120565606	1
Metoprolol	Glyburide	0.537	-Inf	Moderate	9 (0/9)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.939960542545225	1
Estradiol	Primidone	0.024	-Inf	Moderate	1 (0/1)	The metabolism of Estradiol can be increased when combined with Primidone.	#1E61A5	0.104440060282803	1
Carbamazepine	Bupropion	0.23	-Inf	Moderate	13 (0/13)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#1E61A5	1.35772078367644	1
Trazodone	Galantamine	0.292	-Inf	Moderate	2 (0/2)		#1E61A5	0.208880120565606	1
Warfarin	Phenobarbital	0.381	-Inf	Major	5 (0/5)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#1E61A5	0.522200301414014	1
Folic acid	Primidone	0.264	-Inf	Moderate	4 (0/4)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#1E61A5	0.417760241131211	1
Colestipol	Fluvastatin	0.158	-Inf	Moderate	3 (0/3)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.313320180848408	1
Clozapine	Flunitrazepam	1	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Clozapine.	#1E61A5	0.104440060282803	1
Fluconazole	Rifabutin	0.163	-Inf	Moderate	2 (0/2)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#1E61A5	0.208880120565606	1
Ranolazine	Amiodarone	0.436	-Inf	Major	3 (0/3)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#1E61A5	0.313320180848408	1
Dapsone	Trimethoprim	0.1	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Dapsone.	#1E61A5	0.104440060282803	1
Galantamine	Biperiden	0.5	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#1E61A5	0.104440060282803	1
Cyclosporine	Primidone	0.018	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Primidone.	#1E61A5	0.104440060282803	1
Mirtazapine	Rasagiline	0.505	-Inf	Major	6 (0/6)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#1E61A5	0.626640361696817	1
Trandolapril	Lithium cation	0.248	-Inf	Moderate	3 (0/3)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#1E61A5	0.313320180848408	1
Digoxin	Sulfasalazine	0.143	-Inf	Moderate	3 (0/3)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#1E61A5	0.313320180848408	1
Cyclosporine	Piroxicam	0.107	-Inf	Moderate	2 (0/2)	Piroxicam may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.208880120565606	1
Indomethacin	Sotalol	0.083	-Inf	Moderate	5 (0/5)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#1E61A5	0.522200301414014	1
Cimetidine	Clomipramine	0.056	-Inf	Moderate	1 (0/1)	The metabolism of Clomipramine can be decreased when combined with Cimetidine.	#1E61A5	0.104440060282803	1
Clozapine	Carbamazepine	0.15	-Inf	Major	2 (0/2)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#1E61A5	0.208880120565606	1
Verapamil	Rifampicin	0.093	-Inf	Moderate	4 (0/4)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#1E61A5	0.417760241131211	1
Erythromycin	Bromocriptine	0.143	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Erythromycin.	#1E61A5	0.104440060282803	1
Rivastigmine	Methotrimeprazine	0.409	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Clozapine	Flurazepam	0.091	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Flurazepam is combined with Clozapine.	#1E61A5	0.104440060282803	1
Disopyramide	Propranolol	0.396	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.104440060282803	1
Cyclophosphamide	Acenocoumarol	0.129	-Inf	None	2 (0/2)		#1E61A5	0.208880120565606	1
Amikacin	Cefuroxime	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Disopyramide	Carvedilol	0.565	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Carvedilol.	#1E61A5	0.104440060282803	1
Prazosin	Carvedilol	0.8	-Inf	Moderate	1 (0/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#1E61A5	0.104440060282803	1
Erythromycin	Clozapine	0.538	-Inf	Moderate	2 (0/2)	The metabolism of Clozapine can be decreased when combined with Erythromycin.	#1E61A5	0.208880120565606	1
Phenytoin	Prednisolone	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.	#1E61A5	0.104440060282803	1
Cyclosporine	Nabumetone	0.055	-Inf	Moderate	2 (0/2)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.208880120565606	1
Warfarin	Terbinafine	0.187	-Inf	Moderate	6 (0/6)		#1E61A5	0.626640361696817	1
Doxycycline	Benzylpenicillin	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Doxycycline.	#1E61A5	0.104440060282803	1
Testosterone	Acenocoumarol	0.198	-Inf	None	12 (0/12)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	1.25328072339363	1
Fluvastatin	Bezafibrate	0.556	-Inf	None	3 (0/3)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#1E61A5	0.313320180848408	1
Fentanyl	Ketoconazole	0.467	-Inf	Major	4 (0/4)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#1E61A5	0.417760241131211	1
Carbamazepine	Telithromycin	1	-Inf	Major	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Telithromycin.	#1E61A5	0.104440060282803	1
Galantamine	Paroxetine	0.438	-Inf	Moderate	2 (0/2)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#1E61A5	0.208880120565606	1
Mefenamic acid	Acenocoumarol	0.062	-Inf	None	1 (0/1)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.104440060282803	1
Donepezil	Methotrimeprazine	0.172	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#1E61A5	0.104440060282803	1
Sotalol	Glyburide	0.097	-Inf	Moderate	3 (0/3)	Sotalol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.313320180848408	1
Glipizide	Carvedilol	0.474	-Inf	Moderate	3 (0/3)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#1E61A5	0.313320180848408	1
Atomoxetine	Haloperidol	0.2	-Inf	Major	1 (0/1)	The metabolism of Haloperidol can be decreased when combined with Atomoxetine.	#1E61A5	0.104440060282803	1
Doxycycline	Isotretinoin	0.208	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#1E61A5	0.208880120565606	1
Fludrocortisone	Phenobarbital	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#1E61A5	0.104440060282803	1
Phenytoin	Fludrocortisone	0.651	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#1E61A5	0.104440060282803	1
Morphine	Rifampicin	0.537	-Inf	Moderate	3 (0/3)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#1E61A5	0.313320180848408	1
Spironolactone	Benazepril	1	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#1E61A5	0.104440060282803	1
Erythromycin	Felodipine	0.028	-Inf	Moderate	2 (0/2)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#1E61A5	0.208880120565606	1
Tacrolimus	Telithromycin	0.059	-Inf	Major	1 (0/1)	The serum concentration of Tacrolimus can be increased when it is combined with Telithromycin.	#1E61A5	0.104440060282803	1
Haloperidol	Rifampicin	0.04	-Inf	Major	3 (0/3)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#1E61A5	0.313320180848408	1
Doxycycline	Insulin detemir	0.098	-Inf	Moderate	6 (0/6)		#1E61A5	0.626640361696817	1
Cyclosporine	Glipizide	0.125	-Inf	Moderate	1 (0/1)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#1E61A5	0.104440060282803	1
Phenytoin	Disulfiram	0.344	-Inf	Moderate	5 (0/5)	The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.	#1E61A5	0.522200301414014	1
Haloperidol	Glycopyrronium	0.326	-Inf	Moderate	3 (0/3)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#1E61A5	0.313320180848408	1
Benzylpenicillin	Acenocoumarol	0.033	-Inf	None	1 (0/1)	Benzylpenicillin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.104440060282803	1
Warfarin	Cholestyramine	0.226	-Inf	Moderate	2 (0/2)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.208880120565606	1
Rifabutin	Acenocoumarol	0.364	-Inf	None	1 (0/1)	The metabolism of Acenocoumarol can be increased when combined with Rifabutin.	#1E61A5	0.104440060282803	1
Amitriptyline	Galantamine	0.062	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Labetalol	Gliclazide	0.202	-Inf	None	2 (0/2)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.208880120565606	1
Piroxicam	Carvedilol	0.06	-Inf	Moderate	3 (0/3)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#1E61A5	0.313320180848408	1
Methotrexate	Ketoprofen	0.077	-Inf	Major	2 (0/2)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#1E61A5	0.208880120565606	1
Theophylline	Carbamazepine	0.387	-Inf	Moderate	2 (0/2)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#1E61A5	0.208880120565606	1
Fluvastatin	Colchicine	0.237	-Inf	Major	7 (0/7)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#1E61A5	0.73108042197962	1
Alfuzosin	Itraconazole	0.148	-Inf	Major	5 (0/5)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	0.522200301414014	1
Sotalol	Levofloxacin	0.043	-Inf	Major	4 (0/4)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.417760241131211	1
Testosterone	Warfarin	0.481	-Inf	Major	3 (0/3)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.313320180848408	1
Cyclosporine	Propafenone	0.041	-Inf	Minor	1 (0/1)	The serum concentration of Propafenone can be increased when it is combined with Cyclosporine.	#1E61A5	0.104440060282803	1
Propranolol	Clonidine	0.792	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#1E61A5	0.104440060282803	1
Phenytoin	Doxycycline	0.322	-Inf	Moderate	4 (0/4)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#1E61A5	0.417760241131211	1
Methadone	Carbamazepine	0.056	-Inf	Major	1 (0/1)	The metabolism of Methadone can be increased when combined with Carbamazepine.	#1E61A5	0.104440060282803	1
Fluoxetine	Selegiline	0.5	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#1E61A5	0.104440060282803	1
Fluconazole	Eplerenone	0.091	-Inf	Moderate	6 (0/6)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#1E61A5	0.626640361696817	1
Chlorpropamide	Acetylsalicylic acid	0.667	-Inf	None	1 (0/1)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#1E61A5	0.104440060282803	1
Fluvoxamine	Theophylline	0.087	-Inf	Major	1 (0/1)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#1E61A5	0.104440060282803	1
Rifampicin	Propafenone	0.02	-Inf	Moderate	1 (0/1)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#1E61A5	0.104440060282803	1
Atomoxetine	Paroxetine	0.526	-Inf	Major	2 (0/2)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#1E61A5	0.208880120565606	1
Terbutaline	Doxepin	0.062	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Doxepin is combined with Terbutaline.	#1E61A5	0.104440060282803	1
Flurazepam	Ketoconazole	0.029	-Inf	None	1 (0/1)	The metabolism of Flurazepam can be decreased when combined with Ketoconazole.	#1E61A5	0.104440060282803	1
Spironolactone	Cilazapril	0.333	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#1E61A5	0.104440060282803	1
Selegiline	Escitalopram	0.625	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#1E61A5	0.104440060282803	1
Doxycycline	Primidone	0.111	-Inf	Moderate	1 (0/1)	The serum concentration of Doxycycline can be decreased when it is combined with Primidone.	#1E61A5	0.104440060282803	1
Amitriptyline	Rivastigmine	0.3	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Cyclosporine	Sulfasalazine	0.071	-Inf	Major	1 (0/1)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.104440060282803	1
Lamotrigine	Rifampicin	0.1	-Inf	Moderate	2 (0/2)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#1E61A5	0.208880120565606	1
Triazolam	Clarithromycin	0.533	-Inf	Moderate	2 (0/2)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#1E61A5	0.208880120565606	1
Erythromycin	Everolimus	0.024	-Inf	Major	1 (0/1)	The serum concentration of Everolimus can be increased when it is combined with Erythromycin.	#1E61A5	0.104440060282803	1
Cyclosporine	Bupropion	0.25	-Inf	Moderate	2 (0/2)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.208880120565606	1
Griseofulvin	Acenocoumarol	0.089	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.	#1E61A5	0.104440060282803	1
Fluorouracil	Acenocoumarol	0.25	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#1E61A5	0.104440060282803	1
Paroxetine	Selegiline	0.133	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#1E61A5	0.104440060282803	1
Mercaptopurine	Acenocoumarol	0.077	-Inf	None	1 (0/1)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#1E61A5	0.104440060282803	1
Rifampicin	Bupropion	0.408	-Inf	Moderate	2 (0/2)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#1E61A5	0.208880120565606	1
Fluorouracil	Metronidazole	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#1E61A5	0.104440060282803	1
Ziprasidone	Amiodarone	0.444	-Inf	Major	1 (0/1)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#1E61A5	0.104440060282803	1
Metoprolol	Verapamil	1	-Inf	Major	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#1E61A5	0.104440060282803	1
Metoprolol	Terbutaline	0.035	-Inf	Moderate	2 (0/2)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#1E61A5	0.208880120565606	1
Piroxicam	Lithium cation	0.333	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Piroxicam.	#1E61A5	0.104440060282803	1
Dihydroergotamine	Isosorbide mononitrate	0.25	-Inf	Moderate	1 (0/1)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#1E61A5	0.104440060282803	1
Theophylline	Lithium cation	0.021	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#1E61A5	0.104440060282803	1
Doxycycline	Insulin glulisine	0.556	-Inf	Moderate	2 (0/2)		#1E61A5	0.208880120565606	1
Haloperidol	Ketoconazole	0.091	-Inf	Major	1 (0/1)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#1E61A5	0.104440060282803	1
Phenylbutazone	Gliclazide	0.36	-Inf	None	1 (0/1)		#1E61A5	0.104440060282803	1
Warfarin	Rifampicin	0.062	-Inf	Major	1 (0/1)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#1E61A5	0.104440060282803	1
Clomipramine	Rasagiline	0.25	-Inf	Major	1 (0/1)	Rasagiline may increase the serotonergic activities of Clomipramine.	#1E61A5	0.104440060282803	1
Griseofulvin	Acetylsalicylic acid	0.529	-Inf	Minor	2 (0/2)		#1E61A5	0.208880120565606	1
Nortriptyline	Pseudoephedrine	0.125	-Inf	None	1 (0/1)	Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#1E61A5	0.104440060282803	1
Sirolimus	Itraconazole	0.5	-Inf	Major	1 (0/1)	The serum concentration of Sirolimus can be increased when it is combined with Itraconazole.	#1E61A5	0.104440060282803	1
Verapamil	Nadolol	1	-Inf	Major	1 (0/1)	Verapamil may increase the hypotensive activities of Nadolol.	#1E61A5	0.104440060282803	1
Cyclosporine	Digoxin	0.056	-Inf	Moderate	1 (0/1)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#1E61A5	0.104440060282803	1
Spironolactone	Fosinopril	0.029	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#1E61A5	0.104440060282803	1
Eplerenone	Itraconazole	0.066	-Inf	Major	3 (0/3)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#1E61A5	0.313320180848408	1
Digoxin	Tetracycline	0.25	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Metoprolol	Diltiazem	0.297	-Inf	Major	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#1E61A5	0.104440060282803	1
Ceftriaxone	Acenocoumarol	0.053	-Inf	None	1 (0/1)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.104440060282803	1
Lovastatin	Rifampicin	0.048	-Inf	Major	1 (0/1)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#1E61A5	0.104440060282803	1
Ranolazine	Clarithromycin	0.081	-Inf	Major	2 (0/2)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#1E61A5	0.208880120565606	1
Sotalol	Terbutaline	0.02	-Inf	Major	1 (0/1)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.104440060282803	1
Phenytoin	Mebendazole	0.053	-Inf	Moderate	1 (0/1)	The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.	#1E61A5	0.104440060282803	1
Erythromycin	Amiodarone	0.091	-Inf	Major	2 (0/2)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.208880120565606	1
Trifluoperazine	Levofloxacin	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.104440060282803	1
Pimozide	Clarithromycin	0.091	-Inf	Major	1 (0/1)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#1E61A5	0.104440060282803	1
Theophylline	Acyclovir	0.036	-Inf	Minor	1 (0/1)		#1E61A5	0.104440060282803	1
Ranolazine	Itraconazole	0.286	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Itraconazole.	#1E61A5	0.104440060282803	1
Theophylline	Disulfiram	0.167	-Inf	Moderate	1 (0/1)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#1E61A5	0.104440060282803	1
Perindopril	Lithium cation	0.053	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#1E61A5	0.104440060282803	1
Rifampicin	Amiodarone	0.75	-Inf	Major	1 (0/1)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#1E61A5	0.104440060282803	1
Digoxin	Itraconazole	0.122	-Inf	Major	2 (0/2)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#1E61A5	0.208880120565606	1
Fluconazole	Cilostazol	0.094	-Inf	Major	2 (0/2)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#1E61A5	0.208880120565606	1
Eprosartan	Lithium cation	0.091	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#1E61A5	0.104440060282803	1
Ketoprofen	Acenocoumarol	0.043	-Inf	None	1 (0/1)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.104440060282803	1
Carbamazepine	Isoniazid	0.02	-Inf	Moderate	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#1E61A5	0.104440060282803	1
Rifabutin	Simvastatin	0.091	-Inf	None	1 (0/1)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#1E61A5	0.104440060282803	1
Piroxicam	Acenocoumarol	0.143	-Inf	None	1 (0/1)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.104440060282803	1
Glimepiride	Rifampicin	0.1	-Inf	Moderate	1 (0/1)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#1E61A5	0.104440060282803	1
Prednisone	Primidone	0.033	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#1E61A5	0.104440060282803	1
Tacrolimus	Rifampicin	0.038	-Inf	Major	1 (0/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#1E61A5	0.104440060282803	1
Ofloxacin	Acenocoumarol	0.033	-Inf	None	1 (0/1)		#1E61A5	0.104440060282803	1
Sotalol	Formoterol	0.062	-Inf	Major	1 (0/1)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.104440060282803	1
Dextromethorphan	Rasagiline	0.043	-Inf	Major	1 (0/1)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#1E61A5	0.104440060282803	1
Tetracycline	Acenocoumarol	0.143	-Inf	None	1 (0/1)		#1E61A5	0.104440060282803	1
